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The work embodied in the thesis comprises five chapters. The 
first chapter describes a general literature survey of the 
subject matter.' In order to illuminate an otherwise defunct 
period, it is customary to credit ancient scholars right from 
the past history of medicinal chemistry. For example, Ipecac, 
from Brazillian Cephaelis species, was used as an 
antiamebic medication. I^owever, based on superstitions & 
misunderstanding of natural phenomena, their observations 
and interpretations must be regarded as purely heuristic. 
' The research on drugs with major therapeutic action is 
introduced with the mention of earlier agents. Based on 
structural reactivity, bacterial and antibacterial properties, a 
vast multitude of drugs are observed in the present period. The 
role of physico-analytical and organic chemistry in drug 
designing is worth mentioning which provides the best 
solution of the problem developed in biological- environment 
such as unrelated factors, loss of drug by adsorption or 
incomplete absorption. 
The impurities associated with drugs from many sources are 
therefore a subject of great attention by both manufacturer and 
regulatory agencies. The requirements for quality, safety and 
purity warrants careful thought over analytical chemists. 
The classif icat ion of enormous drugs based on their 
chemotherapeut ic action is important which requires a special 
at tention to be elaborated. 
The capital , basic and accessory analytical propert ies have 
been well explained and their goals and relat ionships 
establ ished in hierarchical manner. 
Various quality improving act ivi t ies to ensure the rel iabi l i ty 
of analytical data are discussed. Quality management needs of 
research laborator ies , where drug analysis is carried out on 
non-rout ine basis are well emphasized. 
Due to avai labi l i ty of sub-standard medicine to the general 
public in developing countr ies , it s crucial to assay drug 
samples in formulat ions. Dealing with this concern, we made 
some successful attempts in this direction. The recommended 
methods are val idated following current guidel ines. 
The second chapter describes the analysis of a series of 
penici l l ins e.g. amoxycil l in, ampicil l in, c loxaci l l in , 
benzylpenic i l l in , carbenici l l in & becampici l in in 
pharmaceut ical preparat ions using volumetric and 
spectrophotometr ic methods, s imultaneously as well as 
separately. In simultaneous method, the determination is based 
on a single stage hydrolysis of penici l l ins by dilute sodium 
hydroxide solution under specific experimental condi t ions. 
The degraded products containing sulphur derivat ives are 
neutral ized by dilute hydrochlor ic acid to prevail a pH~2 to be 
conducive for redox ti tration using potassium iodate as t i trant. 
A coloured product containing sulphonic acid is formed at the 
end point in organic layer. Spectrophotometry is performed 
after separat ing the organic layer and measuring the 
absorbance of red-purple colour at 520nm. 
The t i t r imetr ic method using dilute hydrochloric acid for the 
est imation of degraded products of antibiotics obtained after 
the hydrolysis by dilute sodium hydroxide has been found to 
be advantegeous over the old Andrews t i t r imetr ic method. In 
this method strong hydrochloric acid solution is required for 
the quant i ta t ive reduction of iodate to iodine monochloride 
complex. Using a dilute hydrochloric acid solution, it is 
possible to reduce quanti ta t ively iodate to free iodine because 
the degraded products of antibiot ics contain sulphur 
derivat ives which can be oxidized by a very mild oxidizing 
agent. The half reaction (E°) of iodate in strong hydrochlor ic 
acid and in dilute acid respect ively is described below: 
IO'3 + 6 H ' + 2Cl"+4e" 
2IO"3 + 12H"+ lOe' 
" • ICl ' s + 3H2O 
E ' ^ = 1 . 2 3 V 
- • I2 + 6H2O 
E"=1.19V 
The direct spectrophotometr ic method for the determinat ion of 
degraded products of ant ibiot ics is performed under similar 
experimental condit ions, except that excessive iodate ( ImL) is 
used for the redox reaction. The mechanism of degraded 
products is established in the light of TLC, UV and IR 
spectroscopic studies. The stoichiometr ic ratio between the 
analyte (penici l l in) and t i trant (KIO3) is evaluated. 
The resul ts obtained for the degraded products by thin 
layer chromatography conform to the presence of 4-
hydroxymethylene oxazolone. This observation is in agreement 
with previous studies performed under similar condi t ions. 
The reaction mechanism is further aided by conducting IR 
study of the degraded products . The formation of a broad band 
(1500-1350cm' ' ) in spectrum-B is at tr ibuted to the presence of 
4-hydroxymethylene oxazolone. Besides, a strong peak at 
835cm"' in spectrum-C is at tr ibuted to the presence of 
sulphonic acid formed quant i ta t ively. 
The third chapter describes two spectrophotometr ic methods 
for the determinat ion of a non-steroidal anti- inflammatory 
agent, i.e. diclofenac sodium in the visible region of spectrum. 
In the first method, the formation of charge-transfer complex 
with chlorani l ic acid is utalized to carryout est imation. The 
resul t ing predominant chloranil ic acid radical anion is an 
intermediate molecular associat ion compound that exhibits a 
character is t ic absorption maximum at 530nm. The second 
method is based on the reduction of Iron(III) by diclofenac & 
subsequent complexation with 1,10-phenanthroline to form a 
reddish chelate complex, which shows A,max. at 500nm. The 
reduction of Iron(III) and the formation of I ron(II ) -1 ,10-
phenanthrol ine complex depends on pH. The development of 
colour is instantaneous in phosphate buffer solution in the pH 
range 6-8. These two methods are satisfactori ly applied for 
diclofenac content estimation in pharmaceut ical preparat ions . 
In fourth chapter, UV spectrophotometr ic studies are carried 
out to develop two different method3 for the analysis of 
c isapride. In first method, Boyland-Sims oxidation is 
performed for the purpose of its est imation. This involves the 
t reatment of cisapride with peroxydisulphate in alkaline 
medium on heating to yield a yel low coloured product having 
Xmax. at 308nm. This reaction product is stable enough and 
permit est imation with good reproducibi l i ty . In second method 
the oxidimetr ic nature and high solution stabi l i ty of Ce(IV) 
are uti l ized for the quanti tat ive determination of cisapride. 
The acidic oxidation of the drug s tudUd with Ce(IV) yields a 
coloured product having A,max. • • a t ^ 9 n m. Beens^'iaw obeyed in 
\ { Ace. No ) n 
the two methods that are described is in the range 10-
100mgmL"'and 20-120mgmL"' respectively. 
The last chapter describes a kinetic spectrophotometric 
determination of nalidixic acid in bulk, and its 
phamaceuticals. The interaction of nalidixic acid with ferrous 
ammonium sulphate yields a coordination compound, which 
possess X,max. at 420nm. The intensity of colour requires forty 
minutes to get stablized. It is therefore decided to perform the 
kinetic study, which is sensitive, rapid and less time 
consuming. The various reaction parameters evaluated conform 
to the proposed mechanism. The kinetic studies reveal first 
order reaction with respect to nalidixic acid. 
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Chapter-1 
(genera fOnfrodvtcBon 
With the growing global awareness in health hazards and 
environmental pollut ion, Analytical chemistry has played a 
key role to unveil its causes and day by day it has broaden 
its spectrum with the concerned situation. It is extensively 
and intensively responsible for analytical measurements on 
variety of materials such as drug analysis , microbial 
analysis of food, water, cosmetics, agricultural products, 
environmental spi^cies forensic sampling and products 
affecting public health and welfare where quali tat ive, semi 
quali tat ive and quantitative analysis on macro to micro scale 
are performed. In recent decades analytical chemistry has 
reached to the pinnacle of precession with the modern 
sophist icated instrumentation techniques which make 
possible to elucidate the microstructure of molecular 
species, determining antibiotic residues in milk and tissues 
of food producing animals, detection of complex 
hydrocarbons, studies of rare and artificial radioactive 
elements and to obtain substances in the highest state of 
purity. Moreover, with the advent of digital computer the 
precision is further enhanced. However, it has always 
conceived the basic phenomenon of its revelation despite the 
change in instrumentat ion. Analytical excellence has been a 
great boon for chemists, microbiologis ts , entomologists and 
other scientis ts , working in the mult i -discipl inary areas of 
research. 
Medicinal chemistry has taken place in many branches of 
chemistry and biological science. The earlier name of 
pharmaceutical chemistry reflects that pharmacists working 
in their laboratories focussed on the extraction and 
purif ication of naturally occurring drugs. In 1876 the 
pharmacologis t Buchheim wrote that "the mission of 
pharmacology was to identify the active substances with the 
drug, to find out chemical propert ies responsible for their 
action and to prepare synthetic analogs that were 
more effective" [1] . The pharmacologists latter became 
preoccupied with other objectives, such as " to study the 
change brought about the drug in the organism and then to 
explore the possible influence of such changes upon 
pathological condit ion" [1], while the chemist took over the 
role of isolation and chemical identification of biologically 
active consti tuents from medicinally important plants. 
Drug design has also been aided by the understanding of 
biochemical metabolism and biosynthesis , and also by the 
stat ist ical analysis of some relat ionship of physical 
propert ies of chemicals and their biological performance. 
This progress has begun to elevate medicinal chemistry to a 
science in its own right. The fashion in which the drug is 
searched changes, from time to time which is dictated by 
contemporary medical, economical , sociological , and 
sometimes even poli t ical considerat ions. In 1890 
ant iprotozoal chemotherapy set in motion and the early 
synthetic antimaterials intermingled with the development of 
hypnotics and anti- inflammatory drugs. Then followed the 
feverish discovery of ant ibacterials and ant ibiot ics , while in 
pharmacodynamic area the potent analget ics , 
ant ih is taminics , vitamins and new hormones moved to the 
fore. The post world war 11 period featured three major 
breakthroughs in drug research; (i) the anti tuberculous 
agent, (ii) the steroid hormones and contracept ives , (iii) the 
ant ipsychot ic , anxiolytic and antidepressant psychopharma-
cological drug. 
The application of increasingly sophist icated methods of 
structural analysis like spectroscopy, isotopic labeling, 
automated quantitative analysis , separation by 
chromatography and their parti t ion procedures opened 
avenues of study of minute amounts of biochemicals . 
Hahnemann,^ the founder of homeopathy, believed that, 
"Drug's solution should be diluted to the point of practically 
omitting their content of active components because high 
concentrat ion of drugs produce toxic react ions ." Thomson 
stated that "all the diseases arc the effect of one general 
cause and may be removed by one general remedy" [2] . Paul 
Ehrlich, a German physician and immunologist turned 
chemist is the first true exponent drug research as we know 
it today [3]. 
During the period 1940 to 1960, the drug development, 
introduct ion and pharmaceutical manufacturing entered their 
"golden age". Very large proport ion of the important and 
innovative new drugs in medical use were introduced during 
this period. Public expectat ions of new "miracle drugs" led 
to increased funding of medicinal research, especial ly by 
National Insti tute of Health in the United States and by a 
number of wealthy private foundations in several countr ies . 
It is important to recognize that all drugs contain impuri t ies . 
There impurit ies result from many sources; like from raw 
materials and reagents as reaction by-products , and through 
degradation during manufacture and storage. Since, the 
impuri t ies can have safety and efficiency implicat ions, they 
are, therefore, the subject of considerable attention by both 
the manufacturers and regulatory agencies. Impurit ies can be 
classified into three groups, namely organic, inorganic and 
residual solvents. Organic impurit ies may arise from starting 
mater ia ls , intermediates and synthetic by-products , or from 
reagents and catalysts , or as a consequence of degradation. 
Inorganic impurit ies may result from reagents , l igands or 
catalysts , as heavy metals or inorganic salts. Residual 
solvents are inevitable in drug substances since without 
solvents, the synthetic chemistry, purification and 
generation of the desired crystal morphology would be 
impossible . 
Qualif ication is defined as "the process of acquiring and 
evaluating data which establish the biological safety of the 
individual impurity or a given impurity profile at the levels 
specif ied." Thus, the pharmaceutical analyst and 
toxicologist must work hand in hand throughout the pre-
chemical and clinical development programme in order to be 
able to set meaningful specification requirements . The 
methods used for impurit ies measurements , determinat ions 
and qualif ications are addressed in more detail in the 
coming pages. The pharmaceutical analyst must give careful 
thought to the analytical technology. Especial ly in the 
development phases, it may be necessary to util ize methods 
with high selectivity, including sophist icated techniques. 
The importance of qualifying impurity profiles as also 
relevant to the developmental scientists to ensure 
considerat ion is given to the impurit ies present in batches 
being used in safety studies, although there are 
opportuni t ies to carry out metabolic studies to help in the 
qualif ication processes. 
The validation of analytical methods used in bioavai labi l i ty , 
bioequivalence and pharmacokinet ic studies in humans and 
animals has been the subject of discussion in recent years 
[4-8] . It has been agreed that the key for evaluation of 
method rel iabi l i ty and overall performance are; (i) analyte 
s tabi l i ty; (ii) method select ivi ty; (iii) limit of quanti ta t ion; 
(iv) accuracy and precision; (v) relat ionship between 
response and concentrat ion; (vi) recovery; and (vii) 
ruggedness . Before an analytical method can be used for 
routine analysis , it must first be demonstrated that the 
method fulfills certain performance criteria. When this has 
been documented, the method is said to be validated. The 
first and one of main difficulties for the pract icing 
analyt ical chemist is to decide exactly which parameters 
should be measured and to set the performance criteria, 
which have to be fulfilled before a method can be said be 
val idated. Once the parameters have been fixed, it must be 
shown that they meet performance criteria. How to do this is 
the second difficulty that is faced by the analyst . However, 
for a number of years analytical chemists in the 
pharmaceut ical and biomedical field have learnt how to 
demonstrate that their methods have a performance that can 
guarantee reliable results after the advent of good laboratory 
pract ice. We know this exercise as validation of analytical 
methods. In the field of drug analysis , it is very clear that 
the above definitions cover the entire field of analytical 
chemistry from bioanalysis to substance and product 
analysis . This is an important observation, as the same 
principle should apply whatever type of sample is to be 
analyzed. There are a number of definitions given by several 
internat ional organizations [Table 1.1]. Most of them are 
congruent . 
Table 1.1 
Validation of analytical methods-international definitions |9 | . 
Organization 
lUPAC 
ILAC 
WELAC 
ICH 
ISO 
Appl i cab i l i t y 
Worldwide 
Worldwide 
Europe 
Europe, Japan, USA 
Worldwide 
Remarks 
Pharmaceutical 
products 
Lacks selectivity 
and specificity 
ABBREVIATIONS: 
lUPAC-International Union of Pure and Applied Chemistry; 
ILAC-International Laboratory Accreditation Conference; 
WELAC-Western European Laboratory Accreditation 
Corporation; ICH-International Conference on Harmonization; 
ISO-International Organization for Standardization; 
The quality of the analytical information produced 
in a laboratory depends on the quality of the information 
available to managers as they define the analytical problem, 
design the analytical process and adjust it features so that the 
results produced meet the required objectives. It is important 
to have a clear understanding of analytical properties such as 
accuracy and representativeness as well as their relationship 
to quality in the analytical process and to the results. These 
two facets of analysis are frequently dealt with 
inconsistently, resulting confusion in laboratory work and in 
communication with clients or services users. 
Types of analyt ical p rope r t i e s 
Quality in the analytical results, the primary goal of 
analytical chemistry, relies heavily on two capital analytical 
properties; accuracy and representativeness. Accuracy means 
consistency between the results obtained and the actual 
concentration of the analyte in the particular sample, 
representativeness refers to consistency between the results 
and the analysed sample as well as between the results and 
the definition of the analytical problem. Capital properties 
rely on another group of analytical properties that we will 
call basic properties. They determine the quality of the 
analytical process both inside and outside the laboratory 
during sampling. Basic properties are sensitivity, selectivity, 
precision and sampling. The analytical process is also limited 
by seemingly less significant accessory propert ies. These 
properties, however, often have major practical implications. 
They include expeditiousness, cost-effectiveness and 
personal-related considerations, all of which affect laboratory 
output. Figure 1.1 shows two essential components of 
analytica-l quality and displays capital, basic and accessory 
analytical properties in a hierarchical manner. It also outlines 
the generic objectives of present day analytical chemistry; 
obtaining larger amounts of analytical information of higher 
quality by expending less material, time and human resources, 
minimizing risks; and incurring the smallest expenses 
possible [10]. Whereas capital analytical properties are 
associated with results, basic and accessory properties are 
related to the analytical methodology used. 
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Figure 1.1 Goals of analytical chemistry and their 
relationships to analytical quality and 
analytical properties. 
Analytical tetrahedra 
The most straightforward and intuitive form of graphically 
displaying analytical properties involves two tetrahedra that 
share a vertex and can be of varying sizes relative to each 
other [Fig. 1.2]. This illustration provides a useful means of 
distinguishing among the three principle groups of analytical 
properties, establishing a hierarchy, and determining 
symbiotic and opposing relationship among them. Figure 1.2 
also includes sampling, which determines representativeness. 
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Figure 1.2 Analytical tetrahedra. 
The vertices of main tetrahedron (left) depict sensitivity, 
selectivity and precision; one of its faces represents accuracy, 
which relies on these three basic properties. This tetrahedron, 
together with representativeness of sampling, has the greatest 
statistical weight on analytical results and is connected with 
the objectives of obtaining more and better information. The 
secondary tetrahedron (right) has vertices depicting the 
accessory analytical properties; one of its faces represents 
laboratory productivity. This tetrahedron is related to the 
objective^ of minimizing time, costs, labour and hazards. 
Relationship among basic analytical properties 
Figure 1.3 depict the opposing relationships among the three 
basic analytical properties. Enhancing one usually can be 
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achieved only at the expense of the other two. The central 
equilateral triangle represents a balanced situation and can be 
distorted to an isosceles or scalene triangle, depending on 
which property is favoured. The most salient relationships 
among the three properties are discussed below. 
Figure! .3 Relationships among basic analytical properties. 
Prec i s ion and Sens i t iv i ty 
It is well known that precision decreases as analyte 
concentration decreases. Figure 1.4 shows an example of the 
results from intercomparison of food analysis experiments in 
which the coefficient of variation increases exponentially 
with decreasing analyte concentration [ I I ] . Consequently, a 
higher sensitivity method will also be highly variable when 
applied to trace and ultratrace determinations. Incorporating 
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an analytical separation technique to indirectly enhance 
sensitivity and facilitate the determination of analyte 
concentrations below the detection or quatification limit of 
the analytical method used, complicates preliminary 
operations and increases the time spent by the researcher. In 
addition, precision is diminished. 
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Figure 1.4 Relationship between the precision and the cone, 
level of analytes to be determined. 
Sensi t ivi ty and Selectivity 
Not withstanding their seemingly distant natures, sensitivity 
and selectivity are also related and not always in an opposite 
manner. In fact, the difference between the additive and 
multiplicative interferences lies in whether the perturbation 
concerned affect the slope (sensitivity) of the calibration 
curve. The more sensitive the method used to determine a 
given analyte, the more a sample can be diluted to decrease 
the concentration of interferences and hence minimize or 
eliminate their perturbations. The method is widely known 
and exploited in the analysis of clinical/biological samples; 
sensitive methods call for high initial dilutions (1 :10-
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1:10,000) to minimize the typical perturbations of 
niacromolecules. Sensitivity and selectivity can be enhanced 
by similar mechanisms [12]. Newly emerging analytical 
laboratory instruments tend to incorporate these mechanisms 
to enhance their basic analytical properties. The use of non-
chromatographic continuous separation techniques and multi-
channel detectors are good examples in this content. 
Selectivity and Precision 
The uncertainty inherent in the mechanisms described above 
for enhancing selectivity is related to the complexity of the 
analytical process. When several such mechanisms come into 
play, the interminate error arising from each is seen in the 
final results, and precision is diminished. Thus if the 
selectivity of the methodology in question arises from the 
detector used, the analytical process is simpler and higher 
precision is achieved. Appropriate chemometric or simple 
mathematical treatments increase selectivity. Univariate 
calibration and differential kinetic methods [13,14] are two 
good choices. As a rule the use of these methods result in 
poor precision-even poorer than that obtained from analytical 
separation techniques. However, one can use these techniques 
to avoid some stages of the analytical process. 
Accuracy and accessory analy t ica l p roper t i e s 
Designing an analytical method by which to achieve high 
accuracy means that high levels of the basic analytical 
properties must be obtained at the expense of accessory 
properties. As can be seen in Fig. 1.5a, the main tetrahedron is 
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distorted when the area of triangular accuracy face in 
increased. Whereas the secondary tetrahedron is considerably 
shrunk by shifting these forces pointing towards the main 
tetrahedron This situation reflects the priorities among the 
capital, basic and accessory analytical properties 
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Figure I 5 Distortion of the analytical tetrahedra for 
boosting (a)accuracy, (b)accessory analytical 
propeities 
The opposite situation [Figure 1 5b] occurs when temporal, 
economic and /oi personal aspects related to laboratory 
productivity prevail upon the quality of the results. Obtaining 
immediate analytical results in response to an urgent demand 
( e g , in the clinical field) or controlling a process in near 
real time entails sacrificing some accuracy Thus some recent 
applications rely on FT-IR spectroscopy to obtain accurate, 
reproducible results in as short time as possible with 
minimum sample handling and manual involvement [15] 
Occasionally, a timely "yes or no" reply to indicate whether a 
given parameter is above or below the tolerated level is more 
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important than obtaining an accurate analytical result a few 
hours latter. Sensors [16] and screening test based on 
immunoassay [17] are additional good examples. 
Accessory analytical properties 
The accessory properties at the vertices of the productivity 
triangular face of the secondary analytical tetrahedron also 
exhibit opposing relationships. The imposed or advisable 
prevalence of one or two of these properties distort the 
equilateral triangular face and hence disturbs the balance 
among them. When an analytical process is designed to 
enhance one of the three properties viz; cost-effectiveness, 
expeditiousness, or personal safety/comfort-the other two 
sides of the resulting productivity triangular face are 
markedly shortened. If two properties rather than one are 
favoured; the side of the remaining property is contracted. 
Quality Compromise 
Meeting the demands imposed on the information produced by 
an analytical laboratory requires that a compromise be made 
between the two components of the analytical 
chemistry/quality binomial: external quality, which refers to 
the properties of the monitored product or service, and 
internal quality, which deals with the analytical process and 
the results produced. External quality may result from 
compliaiice with legislation or quality requisites for a 
production process. It directly affect the analytical quality, 
which depends on capital, basic and accessory analytical 
properties. From a strictly theoretical point of view, the first 
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situation in accessory properties can be considered ideal-at 
least one should reach the balanced situation depicted in 
F ig l .2 . However the facts may justify this situation depicted 
for accessory properties for the analytical laboratory to meet 
the demands posed by the analytical problem derived from the 
economic or social problem addressed. 
Quality management in drug analysis covers a wide range of 
quality improving activities designed to ensure the reliability 
of the analytical data. These activities include ensuring that 
the sample are properly collected and preserved prior to 
analysis, that the analysis is carried out using the appropriate 
technique, and that the results are properly recorded and 
reported. Emphasis is given on the quality management needs 
of research laboratories where drug analysis is carried out on 
non-routine basis. 
Analyt ica l Techniques 
Drug analysis is taken during various phases of 
pharmaceutical development, such as formulation and 
stability studies, Qc and toxicological and pharmacological 
testing in animals and man. In hospitals, drug analysis is 
performed on patient 's samples in support of clinical trials 
(bioavailabili ty and pharmacokinetic studies) and in 
monitoring therapeutic drugs and drugs of abuse [18-21]. All 
these investigations require reliable and validated analytical 
methods in order to measure drugs in complex media such as 
formulations and biofluids. Because of their selectivity, 
sensitivity and overall versatility, techniques such as GC, 
HPLC, superficial fluid chromatography (SFC) and capillary 
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electrophoresis coupled with selective detectors are 
frequently used to analyse multicomponent drug mixture. 
Immunoassays because of their speed and simplicity are 
mainly used in drug monitoring in patients. Spectroscopic 
(UV,IR, AAS) and titrimetric techniques are routinely used 
in QC work, and TLC & more recently near infrared (NIR) 
spectrometry has been used for the rapid identification of 
impurities and degradation products in pharmaceuticals. 
Personne l 
The quality of the analytical results depends on both 
instrument capability and the professional expertise of the 
user, and therefore for reliable results instruments must be 
used by an adequately qualified trained operators using 
clearly written standard operating procedures. A detailed job 
description should be available and the required level of 
qualifications and experience set for each post. 
E q u i p m e n t and C h e m i c a l s 
When choosing new equipment it is important to ensure that it 
is fit for its intended purpose and its performance is up to 
specification [22]. Other things to be considered are cost, 
ease of use, quality after sales-service and health and safety 
aspects. There should be clear unambiguous, written 
procedures for the operation of the instruments. They should 
give corrfect readings within their specified tolerance limits 
when checked at appropriate intervals by standard procedures 
using reference materials. All standards and calibrators used 
must be traceable to nationally accepted standards. Minor 
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preventive maintenance operations should be established & 
followed, such as keeping pH electrodes in a wet condition or 
storing chromatography columns according to supplier 's 
instructions. Special attention should be given to the quality 
of the laboratory glassware and reagents & standards. 
Reference standards should be prepared according to written 
procedures. For quantitative work, be sure to use good quality 
glassware and analytical reagents and solvents, because other 
grades can contain impurities. Drug substances in pure form 
can be obtained from the suppliers or be requested from the 
manufacturer. Due considerations should be given to the safe 
storage and disposal of chemical and solvents used in the 
laboratory. Finally, as a matter of good housekeeping, one 
should keep laboratories clean, with equipment uncluttered 
and benches tidy [23]. 
Method Development 
Good planning is essential in the selection and development 
of methods for drug analysis. It is necessary to be able 
quantify the active components in the sample rapidly with 
acceptable precision, accuracy and reliability within the cost 
and other constraints. It often happens that during product 
development or any other long-term work, analytical methods 
evolve. A logic and systemic approach is required in method 
selection and development. This can be outlined in four basic 
steps; (a) 'generate background data, (b) review the literature 
(c)develope the method (optimize the experimental 
conditions) and (d) validate the performance of the method 
before using it routinely. Before starting any work, all the 
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initial information on the drug (physicochemical properties 
such as solubility, dissociation constant & UV adsorption) 
and the dosage form or the intended dosage form (strength, 
preservatives, types of container, stability etc.) should be 
collected. For bio-analytical work, adequate information 
about the sample, subject and dosage, including co-
administered drugs should be obtained. All this information is 
useful in setting up the analytical method. Bio-analyt ical 
methods for pharmacological and tdxicological studies must 
be selective and sensitive enough to follow the absorption, 
distr ibution and elimination of the drug. Sensit ivi ty is 
par t icular ly important for paediatr ic or small animal 
samples since their availabil i ty may be l imited. Further 
move biofluid assays must be accurate and precise in order 
to reveal differences between dosage form or subjects 
(human volunteers , patients or animals) . 
Although experience is required in method development 
work, guidance can be obtained from l i terature sources 
special izing in method development [24-31] . Alternat ively, 
one can use one of the commercial ly available software 
packages to speed up chromatographic method development, 
par t icular ly HPLC [32-33] . These systems are developed to 
assist the chromatographer in the selection & optimization 
of condit ions during method development. With the 
assis tance of these systems, maximum information can be 
extracted from a minimum number of experiments . The main 
advantage of expert systems is that they provide immediate 
availabil i ty of an expert opinion through an inherent 
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knowledge base, and respond to the users inquiry when 
presented with a problem. 
Va l ida t ion 
Once the analytical method has been developed, it is 
validated before or during its use. Validation of the method 
establ ishes that its performance character is t ics are adequate 
for the intended use. In pharmaceutical industry, validation 
of analytical method is required in support of product 
registrat ion appl icat ions. 
Many of the principles , procedures and requirements of 
val idat ion are common to the majority of analytical 
methods. Validation is performed by conducting a series of 
experiments using specific condit ions of the method. 
Validat ion does not imply that method is free from error. It 
only confirms that it is suitable for the purpose. Any 
modification to the method during its use require its 
reval idat ion. Some revalidat ion may also be required when 
transferring the method between laboratories or when 
changes are made in the manufacturing process of the drug. 
Once the method has been developed and val idated, it is 
fully documented and approved for the use. It should be 
described in sufficient detail to allow any analyst to use it 
without difficulty. 
Ruggedness 
In addition to the various scientific parameters , another 
useful parameters to consider during validation is the 
ruggedness or robustness of the analytical method. The 
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ruggedness of a method is its ability to remain unaffected by 
small, unintentional changes in the experimental conditions, 
such as; temperature, mobile phase composition and pH, or 
different source^s of reagents and chromatographic columns. 
These occur when a method is used over a long period or is 
transferred to another location. Since the drug development 
work can last for many years and be conducted at more than 
one site, the ruggedness of the method is critical so that it 
can be transferred between laboratories and used by 
different workers. 
System Suitability tests 
Once the method is in routine use, check or system 
suitability test (SST) should be run each time the method is 
used, to confirm that it is performing satisfactorily. Since 
the instrument to instrument variations can have a 
significant effect on the assay, SSTs provide added 
assurance that on specific occasion the method is giving 
acceptable results. SSTs should not be confused with good 
method validation, which is carried out at the method 
development stage. SSTs on the other hand, check the 
performance of a given system on a given day prior to 
analysis. SSTs can detect normal changes in the equipment 
during normal usage. If the method is robust enough, it 
should not fail such tests. SSTs are particularly useful in 
routine QC work & stability studies. 
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Method compar i son 
The performance of a newly developed or modified method 
can be assessed by comparing the results obtained by it with 
those found with a reference method of known accuracy and 
precis ion using linear regression analysis [34-37], A 
reasonable number of samples evenly spaced over a 
concentrat ion range of interest are analysed by both the 
candidate method and the reference method. However it is 
not always possible to conduct method comparison studies 
simply because a suitable reference method is not routinely 
avai lable, or is costly requiring special facil i t ies. 
Solu t ions & Reagents 
Standard solution of drugs in water or methanol are used 
during many stages of analysis , such as calibration and 
val idat ion. In bioanalytical work, although stock solutions 
can be prepared in water or methanol, standard solution for 
cal ibrat ion and other experiment should be prepared by 
dilution of the stock solution with a relevant biological 
fluid, since aqueous solution differ greatly from the 
biological matrix. Drugs and reagents are sorted in such a 
way to maintain their integri ty. In general solutions of drugs 
& chemical are more stable at low temperatures (4or-20°C) 
than at room temperature. All solutions must be clearly 
labeled with preparation and expiry dates. Stock solution of 
photo-decomposable substances should be stored in amber 
colored containers and those of very unstable and volati le 
substances should be freshly prepared. 
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Samples 
Sampling is often considered to be a weak link in the quality 
chain part icularly in drug bioanalysis , and is often the major 
contr ibutor to measurement error. Samples should be 
homogeneous and representat ive of the original material . 
The sample taking should be carried out in accordance with 
the approved procedures. It is essential that the samples are 
collected in a suitable container at the correct time in 
relat ion to the dose correctly labeled and preserved under 
appropriate conditions [38-41]. The laboratory must have a 
rel iable system of documentation of samples from receipt in 
the laboratory to the disposal of the reminder. Samples must 
be unpacked in a suitable area taking into account any safety 
requirements . If the entire sample received by the laboratory 
is not init ially required, it should be divided into sub-
samples, taking precautions to avoid contamination and 
losses through spil lages. This practice is useful in case a 
repeat assay is required at a latter stage. 
Analys is 
All analyses should be carried out in accordance with 
writ ten procedures. Assays should preferably be performed 
in duplicate each time using a separate portion of the sample 
rather than a repeat determination on final solut ions. A 
complete repeat analysis gives confidence in the results and 
serves to check on the homogeneity of the sample and the 
random variat ion in the instrumental response [42]. The 
laboratory should maintain records of the results as a matter 
of professional policy. The test performed, results and 
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relevant observations should be written down in a laboratory 
notebook and corresponding copies of the instrument traces 
stored. The notebook should serve as a record of each days 
work so that each step in the analysis can be traced at a 
latter stage if required. 
Internal & External Quality Control 
Internal QC is usually applied to drug bioanalysis to 
monitor assay performance with regard to accuracy & 
precision [43]. This is done by analyzing specially prepared 
QC samples along-side a batch of samples and plotting the 
results of QC samples on a QC chart [44-46]. Like 
calibration standards, QC samples are prepared by adding 
known amounts of drug in the biofluid. Usually, two 
concentrations of QC samples, one near the top and the 
other near the bottom of the calibration range, a third QC 
samples in the middle of the range are used. For an assay 
with a wide calibration range, a third QC sample in the 
middle of the range can be tested. If the method is working 
satisfactorily, the results of the QC sample should fall 
within the pre-set limits, typically + 10% of the known 
values. 
If a laboratory offers drug analysis as a part of a routine 
service, it is useful for such a laboratory to participate in a 
an external QC scheme (preficiency testing scheme) 
involving many laboratories, provided the drugs in question 
are included in such a scheme. In an external QC scheme, 
identical samples are periodically sent to the participants 
for assay, and the scheme coordinator after receiving the 
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results reports the labora tory ' s performance together with a 
summary of results from all par t ic ipants . Market 
improvement in analytical standards over a period is 
consistent finding with many quality assessment schemes. 
Only certain groups of drugs, such as ant iconvulsant , 
ant idepressants and benzodiazepines , are monitored by 
external quality assessment scheme. However, regular 
par t ic ipat ion in such schemes is an effective way to measure 
the competence of laboratory to undertake certain analyses. 
Acc red i t a t i on 
In addition to proficiency testing schemes, increasing 
at tention is being given to external quality assessment 
schemes by which a laboratory has to prove its competence 
to an independent third party by par t ic ipat ing in a 
recognized external quality assessment scheme. Laboratory 
Accredi tat ion is a formal recognit ion by an authorized body 
such as National Measurement Accredi tat ion Services 
(NAMAS) that the labora tory ' s quality system is in place 
and meets the required standards to carry out specific tests 
or specific types of tests. Accreditat ion is normally awarded 
following successful assessment of the l abora tory ' s system 
by NAMAS officers and is subject to periodic review. Much 
emphasis is placed on documentat ion, cal ibrat ion of 
equipment, staff competence and training and traceabil i ty of 
s tandard-mater ia ls . Accredi tat ion gives the laboratory and is 
customers added confidence in the quality of resul ts . 
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L a b o r a t o r y Aud i t 
Cost considerat ions prevent laboratories from jo in ing a 
proficiency or accreditat ion scheme. In this si tuation, it is 
useful to conduct an in house audit of the labora tory ' s 
quali ty management system at appropriate intervals say at 
least once a year. Auditors should preferably be independent 
of the activit ies of the laboratory that they are going to 
audit . Audit should cover all aspects of the laboratory 
pract ice from sample collection to report ing results , and not 
jus t analytical performance. It should be sufficiently 
probing to highlight any drawback in the service. The use of 
audit is the most reliable way of identifying problems in the 
management of the laboratory. Quality management in drug 
analysis incorporates all measures taken to ensure the 
rel iabi l i ty of analytical data, starting from obtaining a 
satisfactory sample, analyzing it correctly with a val idated 
method, to reporting the results , with all procedures well 
documented and periodical ly reviewed. By implementing an 
effective quality system, a significant improvement is made 
to the overall performance of the laboratory engaged in drug 
analysis . 
All the drugs in their nature are divided into inorganic and 
organic. Both can be prepared from natural sources, or 
art if icially, i.e. synthet ical ly. The enormous number of 
drugs used in medicine can be classified into two way; 
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1. Pharmacological Classification 
In this section, drugs are divided on the basis of their action 
on an organism (the heart, lymphatic system, stomach, 
intest ine etc.) . Accordingly, drugs are divided into such 
groups as norcot ics , soporifics, analgesics , diuret ics and 
local anaesthet ics . 
2. Chemical Classification 
Here, the drugs are divided according to their chemical 
structure and propert ies regardless of their pharmacological 
action. It is beyond the scope of this thesis to discuss all the 
type of drugs, however, few important classes of compounds 
used as drugs are discussed below. 
Alkaloids 
Alkaloids are substances mostly of plant and rarely of 
animal origin. In medicine, alkaloids are successfully used 
as drugs in the treatment of cardiovascular , nervous, 
al imentary trace and many other diseases [47]. They are 
organic substances of basic nature because their molecules 
always contain nitrogen. The alkaloids are chiefly tert iary 
amines, and only some of them are secondary amines or 
derivatives of te t rasubst i tuted ammonium bases. Such class 
of drugs can be grouped into the following heads. 
(i) Pyridine & Piperidine derivatives ( l ibel ine & its 
companions) . 
(ii) Tropane derivatives (atropine, hyoscyamines, cocaine 
etc.) . 
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(iii) Quinoline derivatives (quinol ine, quidine etc.) 
(iv) Isoquinoline derivatives (opium) 
(v) Indole derivatives (physost igmine, reserpine etc.) 
(vi) Imidazol derivatives (pi locarbine, omeperazole) . 
(vii) Purine derivatives (caffeine, theobromine, theophyll in 
etc.) 
An t ib io t i c s 
Antibiot ics are very important class of pharmaceut icals 
consist ing of ant ibecter ia ls , ant i - infect ives, antifungals, 
ant iparasi t ics and ant imicrobials . Antibiot ics are organic 
compounds derived from or produced by living organisms, 
which are capable, in small concentrat ions, of inhibi t ing the 
life processes of micro-organisms [48]. 
The chemistry of antibiotics is so varied that a chemical 
classif ication is of little value. However, some antibiot ics 
are the products of similar mechanism in different organisms 
and that these structurally similar products may exerts their 
act ivi t ies in a similar manner. A number of ant ibiot ics have 
in common a macrolide s tructure, a large lactum ring. 
Erythromycin, Oleandomycin are included in this family. 
Tetracycl ine family represents a group of compounds very 
closely related chemically. Streptomycins, kanamycins, 
neomycins, paramomycins and gentamycins are included into 
a family of compounds containing closely related amino 
sugar moit ies . The antifungal ant ibiot ics , nystat ins and 
amphotericins are examples of a group of conjugated 
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polyenes. The pencillins and cephalosporins are antibiotics 
derived from amino acids. A large number of polypeptide 
compounds that exhibit antibiotic action include bacitracine, 
tyrothricins and polymixins. 
Analgesics 
A drug which brings about insensibility to pain without loss 
of consciousness is known as analgesic. There are numerous 
drugs which, in addition to possessing distinctive pharma-
cologic activities in other area may also possess analgetic 
properties [49]. The analgetic property may have direct or 
indirect effect. Such class of drugs are grouped as 
sedatives.(e.g. barbutrates), muscle relaxants, tranquilizers, 
(e.g. meprobamate), morphine and related compounds, Some 
of them been quantitatively analysed in pharmaceutical 
preparation [50-53]. 
Central Nervous System Depressants 
The agents that produce depressant effects on the central 
nervous system [54] as their main pharmacological action, 
include the general anesthetics, hypnotic sedatives, skeletal 
muscle relaxants, tranquilizing agents and anticonvulsants. 
The general anesthetics (e.g. ether) and hypnotic sedatives 
(e.g. phenobarbital) produce generalized or non-selective 
depression on C.N.S function. Many sedatives if given in 
large doses produce anesthetic effect. Certain analgesics 
also produce depression on central nervous system. 
Central Nervous System Stimulants 
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Central nervous system is a complex network of sub-units 
which acts as conducting pathways between peripheral 
receptors and effectors, enabling one to respond to his 
environment. Drugs which have in common the property of 
increasing the activit ies of various portions of the central 
nervous system are called central nervous system stimulants 
[55] . 
Respiratory Stimulants and Analeptics 
Carbonic acid is a most effective respiratory stimulant. 
Analeptic agents used to lessen narcosis brought about by 
excess of depressant drugs often stimulate a variety of nerve 
centers as well as many analeptic drugs are also predecessor 
drugs because their st imulation of the vasomotor center 
produce an increase in vasoconstr ic t ion. There are many 
drugs (e.g. cocaine, a troprine, amphetamines, ephidrine etc.) 
of varying pharmocologic classes, which in addition to their 
desired effects, elicit a pronounced st imulatory effect on 
central nervous system. 
Cardiovascular Agents 
Agents used for their action on the heart or on other parts of 
the vascular system to modify the total output of blood for 
the distr ibution to certain parts of the circulatory system, 
are called cardiovascular agents. This class include 
cardiotonic drugs, vasodiala tors , hypotensive drugs, 
ant ihypercholes tero- lemic drugs and s c l e r o s i n g agents 
[56]. Certain drugs have a direct action on cardiovascualr 
system, and in addition, they affect certain const i tutents of 
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blood. The later include ant icoagulants , the hypoglycemic 
agents, the thydroid hormones and the anti thyroid drugs. 
Analysis of Drugs 
The methods for analyzing medicinal agents are divided into 
physical , chemical, physio-chemical and biological ones. 
Physical methods of analysis involve the studying of the 
physical propert ies of a substance. They include the 
determination of solubili ty, t ransparency and the degree of 
turbidity, density or specific gravity, melting, boiling and 
freezing points. 
Chemical methods used for the analysis of drugs are based 
on chemical reactions. They include the determination of 
ash content, the hydrogen ion concentrat ion, (pH) of 
medium, and characteris t ic numerical indices of oils and 
fats. Quanti tat ive and quali tat ive analysis of drugs are 
generally carried out with respect to functional groups. 
Physio-chemical methods are used to study the physical 
phenomenon that occurs as result of chemical reaction. 
Among the physio-chemical methods of analysis are, 
photometry including photo-colorimetry and spectrophoto-
metry, electrochemical and chromatographic methods. 
Recently, various kinds of chromatography (column, paper, 
thin layer, gas, gas-l iquid) and photometeric methods based 
on the absorption of light by the analyte have found their 
use in pharmaceut ical analysis . NMR and mass spectrometry 
with gas chromatography are the most important analytical 
methods used for the analysis of drugs. 
31 
Biological methods of analysis characterize the 
pharmaceut ical effect of the drug. Biological tests are 
conducted on animals and less frequently on separate 
isolated organs or parts of organs of animals. The effect of 
drugs is expressed in A.U, (Activity units) and is 
determined by the comparison with the activity of a 
reference substance. The biological methods are very 
sensi t ive. Alkaloids, vitamins and antibiot ics still reveal 
activity when diluted millions of t imes. 
Photocolorimetr ic methods of analysis are based on 
measuring the absorption of non-monochromatic light by 
coloured compounds, in the visible part of the spectrum. If 
the analytes are colourless, they are converted into coloured 
compounds by reaction with suitable reagents. In the visual 
method, called colorimetry, the intensity of the colour of 
analyte solution is compared to that of standard solution if 
the concentrat ion of substance is known. 
In recent years pharmaceutical analysis has been 
character ized by the use of methods such as 
f lamephotometry and differential spectrophotometry in the 
quali tat ive analysis of drugs. These methods enable one to 
determine the large amount of individual components of a 
mixture because the absorbance of the analyte solution is 
measured not relative to the pure solvent (or a solution of 
reagent) but relative to a reference solution containing a 
known amount of the analyte. 
Magne t ic resonance imaging (MRI) has achieved an 
amazing level of success in clinical medicine as a non-
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invasive diagnostic tool. Moreover, NMR spectroscopy is 
favoured by chemists as a pov^erful technique for molecular 
structure determination. It therefore seems natural that these 
clearly related techniques should merge to yield non-
invasive, spatially localized NMR spectroscopy for 
determining molecular structure and concentrat ion in vivo. 
Considerable effort has been directed towards developing in 
vivo NMR spectroscopy as a clinical diagnostic tool. Less 
commonly, in vivo NMR spectroscopy has been used to 
monitor drugs as well as other xenobiotic agents directly in 
both human and animal studies. The magnitude of the 
pharmacologic or toxic effect of a drug is expected to 
depend on the concentrat ion at the receptor sites, which are 
generally located in the tissue cells of the target organ [57]. 
Measuring drug levels in plasma is a reasonable method for 
monitoring drug therapy. It is also relat ively non-invasive 
and inexpensive, and a wide range of analytical techniques 
including high-resolut ion NMR spectroscopy [58], can be 
used for quantitation or identification of drug metabol i tes . 
NMR spectroscopy can, in principle measure drug 
concentrat ion in tissue in vivo and can probe drug 
metabolism if metaboli te resonances are resolved. Because it 
is non-invasive, NMR spectroscopy can be used repet i t ively 
on the same individual permitt ing pharmacokinet ic and 
longitudinal studies. 
C a p i l l a r y e l ec t rophores i s , with its two major modes, 
capil lary zone electrophoresis (CZE) and micellar 
e lectrokinet ic capillary chromatography (MEKC), is gaing 
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acceptance in the pharmaceutical field for the determination 
of drugs in formulation [59,60] . Sampling preparat ion 
involving dissolution and dilution of the formulations in the 
running buffer is perfectly adequate. 
Chemi luminescence is a powerful tool for drug analysis 
since its detection limits are extremely low and its 
instrumentat ion very simple and of low cost. In combination 
with derivatizat ion techniques in order to increase 
sensi t ivi ty, it has a wide range of appl icat ions. The 
excellent sensit ivity and the versat i l i ty of the 
chemiluminometr ic methods of analysis are the main reason 
for the recent surge of interest in CL. The introduction of 
flow injection analysis and liquid chromatography with 
chemiluminometr ic detectors is responsible for the plethora 
of original research work devoted to this area of chemical 
analysis . 
Multiple linear regress ion (MLR) is the most common 
choice for mult icomponent determination which allows the 
easy resolution of complex mixtures provided the 
contr ibut ion of each mixture component to overall spectrum 
can be determined from the spectra of the pure components 
used for calibration [61,62]. While rather limited in scope, 
the method provides good results if background noise is 
fairly low and all the mixture components are known, absorb 
appreciably, and do not interact with one another. When one 
or more of these conditions is not met and some analyte 
absorbs weakly at a high concentrat ion of the analyte 
contr ibut ions to the mixture, absorbance are rather 
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desperate, a different mathematical procedure is required. 
Foremost among these is partial least-squares regression 
(PLSR) [63-65] , which is also used with other analytical 
tecniques where interaction between analytes are quite 
strong (e.g. in IR and NIR spectroscopy). 
In Cap i l l a ry e l e c t r o c h r o m a t o g r a p h y ( C E C ) , a liquid 
mobile phase is driven through a stat ionary phase in a 
packed capil lary column by the electro-osmotic flow (EOF) 
generated by a large difference in potential across the 
column. There is no pressure drop, and it follows that the 
flow profile is rectangular and that small diameter part icles 
may also be employed. Higher column efficiencies can 
therefore, be obtained than in pressure driven HPLC. While 
much interest has been shown in the theory and mechanism 
of CEC, its development and eventual widespread use in the 
pharmaceutical industry will only come about if CEC is 
shown to have advantages over more conventional HPLC in 
routine use. CEC can be applied with considerable 
advantages in the analysis of pharmaceutical compounds. 
Separat ions are efficient, repeatable and reproducible . As 
long as the pressure is pressurized and the column 
temperature controlled, quanti tat ive analysis can be carried 
out with electrokinetic injection. CEC has been applied to 
the separation of several pharmaceutical compounds; a 
mixture of diastereoisomers, not previously separated on a 
chiral HPLC column, was separated by CEC [66], 
Der iva t ive s p e c t r o p h o t o m e t r y presents greater selectivity 
than does normal spectrophotometry and so offers a 
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convenient solution to the problem of resolving spectral 
overlap in the analysis of multicomponent system [67-68]. 
Peak-to-peak and base-line measurement (generally referred 
to as graphical measurements) and zero-crossing 
measurements are the most common techniques used to 
prepare analytical working curves. The zero-crossing 
method involves the measurement of the absolute value of 
the total derivatives spectrum at an abscissa value 
(wavelength) corresponding to zero-crossing point of the 
derivatives spectrum of the interfering component. At this 
wavelength, the amplitude of the derivative signal of one of 
the two components passes through zero; measurement of 
the value of derivative spectrum of mixture, made at the 
zero-crossing point of the derivative spectrum of one of the 
components is therefore a function only of the concentration 
of the other component [69]. 
Difference specti ophotometery has proved particularly 
useful in the determination of medicinal substances by 
eliminating specific interference from degradation products, 
co-formulated drugs and also the non-specific irrelevant 
absorption from the formulation matrix. Its advantages for 
selective analysis have been described by several workers 
[70-71]. The technique involves the reproducible alterations 
of the spectral properties of the absorbance difference 
between two solutions provided that the absorbance of the 
other absorbing substance is not affected by the reagents 
used to alter the spectral properties. Simple aqueous acids, 
alkalis & buffers are most frequently used for inducing 
spectral alterations since many drugs are weak acids or 
36 
bases whose state of ionization and absorptivity depends on 
the pH of the solution. [72]. 
Flow injection analysis (FIA) is characterized by its 
simplicity, speed and the use of in-expensive equipment. Its 
results are accurate and precise, and there are clear 
advantages in terms of the short time required for each 
assay. The usefulness of the (Fl) method for routine analysis 
has been shown in a large number of determinations 
developed for clinical, pharmaceutical, food and 
environmental analyses. 
High performance thin-layer chromatography (HPTLC) is 
particularly attractive as an analytical tool as it is the 
fastest chromatographic technique and flexible enough to 
analyse different kinds of samples. It is an off-line 
technique where every stage of the analyses can be 
visualized. HPTLC depends on the object, scanning is 
performed in reflectance and its transmittance made by 
adsorbance or by fluoresence. It can be used in 
pharmaceutical, medical, biological/clinical areas. 
Electrochemical methods are characterized by high 
sensitivity, selectivity and accuracy. Analytical sensitivity 
attainable even exceeds pg./mL level and analysis in the 
nanogram or subnanogram range is possible. 
Electrochemical methods have been extensively developed 
and each basic electrical parameter namely current (i), 
resistance (r) and voltage (v) has been utilized alone or in 
combination of analytical purposes. Electrochemical 
methods have entered a new phase since development of 
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electrochemical detectors for HPLC. These are amperometric 
or coulometric detectors which measure the current 
associated with the oxidation or reduction of solute. 
Pharmaceutical drugs containing groups such as phenolic, 
amino, heterocyclic nitrogen, keto and aldehyde undergo 
oxidation at characteristic potential. Since all compounds do 
not undergo oxidation at a particular potential applied, this 
increases the selectivity of the technique. Electrochemical 
detection is often used where ultraviolet detectors do not 
have sufficient sensitivity. 
Conventional UV spectrophtometeric methods are simple, 
quick, economical and usually do not require an elaborate 
preparation step prior to assay. However, a UV method is 
not adequate when two or more drugs with similar UV 
spectra are present in the sample, or excipients or 
decomposition product exhibits UV interferences, as the 
case with the dissolution testing of phenytoin capsules [73]. 
The principle and the application of the kinetic methods 
have been reviewed [74]. Essentially, kinetic method relay 
on measurements of concentration changes (detected via 
signal changes) in a reactant with time after the sample and 
the reagents have been mixed. The use of kinetic methods in 
micellar media [75] is another approach to kinetic-based 
determinations that have proved useful in drug analysis. 
Micelles increase the reaction rate (through micellar 
catalysis) and may additionally increase the sensitivity and 
selectivity for the analyte. On the other hand, new kinetic 
chemometric (kinetometric) approaches such as the Kalman 
filter has been developed and applied to the simultaneous 
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determinat ion of various compounds of pharmaceutical 
interest . 
The analysis of drug entai ls , essential ly the following; 
(i)the quanti tat ive, quali tat ive and relative bioact ivi ty assay 
of pure and impure drugs in different matr ices; (ii) 
e lucidat ion of the mechanism of action of drugs at the 
molecular level; (iii) clinical evaluat ion, including 
assessment of site of action (in vivo) and side effects, and 
methods of assaying development of resis tance of cells to 
drug action. 
Methods of quanti'^ative and quali tat ive analysis of drugs are 
important in all three aspects. Quanti tat ive drug 
measurement require to be of high reproducibi l i ty , precision 
and accuracy should be efficient. Drug abuse also leads to a 
need for quali tat ive and quanti tat ive analysis of drugs, but 
because dosage forms are of high purity and precisely of 
known composit ion the limits of detection are not so 
demanding as in clinical medicine and reasonably large 
quanti t ies of sample are usually available. 
The methods currently available may be broadly divided into 
two categories; (1) classical microbiological methods [76] 
and modifications there of ;(2) physiochemical techniques 
[77]. 
Microbiological assays may be considered as variants of 
chemical assays in which a living organism or t issue is the 
reagent responding to the substance under invest igat ion. The 
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classical techniques can be classified into (a) diffusion 
methods and (b) dilution techniques. 
Respirometr ic methods depend on the ability of a drug to 
inhibit formation of carbon dioxide by either direct or 
indirect action. Radioactively labeled carbon dioxide, and 
indicator methods can be used, but the indicators should not 
interfere by complexing with the drug. 
Turbidimetr ic methods measure the inhibit ion of growth 
photometr ical ly . The growth is assumed to be inversely 
proport ional to the drug concentrat ion. Errors can be caused 
by variat ion in inocula, inoculum volume errors & light 
absorption by the drug. 
In dilution methods, several dilutions of the drug are 
incubated with an inoculum of test organisms, and the 
lowest concentrat ion of drug, producing complete inhibit ion 
of growth is taken as the inhibitory concentrat ion. 
Numerous variation of these techniques continue to be 
reported, and routinely practised in clinical and 
pharmaceut ical laboratories . One of the primary reason for 
this is that the structure of the drug need not be known. The 
methods are also usually cheap and simple and do not need 
elaborate apparatus, but are slow, have rather poor 
reproducibi l i ty and are open to subjective error, and can not 
be used quali tat ively. 
The availabil i ty of sub-standard medicines to the general 
public poses many problems, both cl inically and 
economical ly. It is widely believed that such sub-standard 
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preparat ions are readily available in many developing 
countries [78-79]. This may be due to poor manufacturing 
procedures , poor storage conditions or deliberate 
counterfei t ing of branded or generic products . However, 
most l i terature reports on this problem do not contain 
quanti tat ive information. 
As a part of an on-going study looking at the quality of 
selected pharmaceut icals in developing countries it is 
necessary to assa> samples of the drugs in formulat ions. In 
examining the quality of the active ingredient present , it is 
of advantage to be able to detect starting materials and 
major decomposit ion products if these are present. This may 
allow the cause of any lack of quality determined. The 
method employed should allow rapid determination of the 
drug from the dosage forms with little sample pretreatment. 
In addit ion the method should be validated following current 
guidel ines [80-81] and in view of this a method is required 
which is as simple as possible so that the val idat ion 
requirement could be adhered to. 
Antibiotics 
Antibiot ics are defined as compounds that have inhibitory 
activity against micro-organism, eukaryotic cells , viruses 
that are produced by secondary metabolism of living 
organism.s, and that possess a variety of widely different 
s t ructures . In 1929, Fleming discovered a mould of the 
penici l l ium species, which inhibited the growth of certain 
bacteria. The antibiot ics cover a wide range of compounds 
of different chemical structures. Penicill in is a name given 
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to the mixture of natural compound having the molecular 
formula C9H11N2O4SR, and differing only in the nature of R. 
There are at least six natural penici l l ins (Table 1.2). 
Tab le 1.2 
Chemical name 
Pen t -2 -eny lpen ic i l l in 
Benzylpen ic i l l in 
p -Hydroybenzy lpen ic i l l i n 
n -Hepty lpen ic i l l in 
n - A m y 1 p e n 1 c 1111 n 
phenoxymethy lpen ic i l l in 
Other name 
Penic i l l in- I or F 
Penic i l l in- I I or G 
Penic i l l in -III or X 
Penic i i l in - IV or K 
Dihydro-F-pen ic i l l in 
Penic i l l in -V 
R 
-CH2CH = CHCH2CH3 
-CH2C6H5 
-CH2C6H4OH (1,4) 
-(CH2)6CH3 
-(CH2)4CH3 
-CH20C6H, 
The penici l l ins are strong monobasic acids, i.e., they are 
known to form salts The penicil l ins get hydrolyzed by hot 
dilute inorganic acids, and one carbon atom is eliminated as 
carbon dioxide, and two products in equimolar proport ion 
are obtained, one being an amine (Penici l lamine) , and the 
other an aldehyde, (Peni l loaldehyde) . All the pencil l ins 
yield same type of amine, but the aldehydes formed are 
different. It is these aldehydes which contain the R group. 
The R group in commonly available penici l l ins is given in 
table 1.3. 
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Table 1.3 
Penicillin R-group 
Ampicillin 
Amoxycillin 
Cloxacillin 
Benzylpenicillin 
v\ // 
H0< A // 
v\ // 
CH-
NH2 
T 
NH2 
• c — c -
N C 
0 TH3 
A // CH2 — 
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The first successful synthesis of penici l l in was carried out 
by Sheehan et al., (1957,1959) , after sixteen years in the 
preparat ion of totally synthetic penici l l ins . The general 
reaction sequence is outlined in F ig l . 6 . 
R \ , 
-NCHCHO 
COjCMe, 
\ 
R' 
-NCH-
C02CMe3 
HSCMe, 
NHjCHOjH 
S CH, 
COjH 
\ 
R ' 
-NCH- ^ 
COjCMe^ HN 
CH, 
COjR' 
ii'yl iici 
\ 
.NCH-
CO,ll 
\ 
SOCI, 
COjIV 
0 
r 
N-
CH, 
Hj-Pd 
CO^R' 
R-^TIT 
or OH" 
S . .CH3 f CH, 
COjH 
^x,_^^N. 
-N 
'l^ ^^J,^ ^^^ ^N-C,H,CH,SOjNH-
R'= CH3, QHjCHj 
Fig 1.6 Total Syiillicsis of penitilliii juialogs. 
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The two commonly used semisynthet ic P-lactum antibiotics 
are ampicil l in (oc-aminobenzylpenicill in) and amoxycil l in 
(oc- amino-p-hydroxybenzylpenic l l in) . These are widely used 
for the treatment of bacterial infections. The analysis of 
these aminobenzylpenci l l ins is carried out by most of the 
analytical techniques. They include flourimetry [82], 
spectrophotometry [83-84], e lectroanalyt ical [85] chromato-
graphic [86-87] and microbiological[88] methods. The 
spectrophotometr ic determinat ions for the assay of 
ampicil l in and amoxycil l in are based on equilibrium 
methods, which involve a previous step where an acid [83-
84] or base [89] hydrolyses the P- lactum ring. About 20min 
to 2hrs. are required for such treatments, so the equilibrium 
determinat ions are slow and hinder applicat ions to routine 
analysis . 
Ampicil l in and cloxacil l in, due to the presence of P-lactum 
and thiozol idine rings possess similari ty in their s tructures, 
and a method for their analysis in combined preparat ions 
must be designed to achieve a high degree of selectivi ty [90] 
but only liquid chromatographic methods are selective. A 
broader spectrum of antibacterial activity is provided by 
penici l l in in combinations and may be advantageously 
prescribed in cases of (3-lactamase producing strains. 
Synergist ic activity are reported for some pencill in 
combinat ions against gram-negative bacteria [91-92]. 
Amoxycil l in (Fig.1.7a) and dicloxacil l in (Fig.1.7b) also 
possess synergy against clinical isolates of P-lactamase 
producing & non-producing strains [93]. 
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HO o CH-CONH. 
NH2 
(a) 
H H 
O ^ 
-N-
S .CH3 
CH3 
CO2H 
i / S . .CH3 
Figure 1.7 (a & b) 
Pharmaceutical preparations containing above mentioned P-
lactum antibiot ics are readily available in the market. A 
variety of analytical procedures are recommended for the 
determinat ion of amoxycil l in, which include spectro-
photometr ic measurement of the copper chelate [94] or the 
formation of penici l lenic acid by treatment with mineral 
acids & copper (II) [95]. The t i tr imetric procedure is 
recommended in British pharmacopoeia [96], for 
amoxycil l in in bulk form using standard mercury (II) nitrate 
and potent iometr ic detection of the equivalent complex, and 
a colorimetr ic one using immidazole mercury reagent at 
325nm in case of capsules containing the drug. Two 
chromatographic procedures are reported for the assay of 
ampici l l in in the presence of another penici l l in [97-98] . The 
first method involves the estimation of ampicil l in embonate 
and amoxycil l in embonate [97], The reverse phase 
separation column is used at pH~7 with detection at 240nm. 
Amoxycil l in is used as the internal standard for ampicillin 
while phenoxymethylpenici l l in that for amoxycil l in. 
Amoxycil l in and embonic acid are determined 
s imultaneously while separate analysis is required for 
ampicil l in and embonic acid. Another method involves 
reverse phase-18 determination of ampicil l in and cloxacillin 
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in capsules [98]. Simple dilution with sulphamethoxazole 
solution is made for sample preparation and determination is 
achieved at 254n;n. Other methods for chromatographical ly 
determining a single penici l l in include the determination 
and monitoring of azlocil l in during bulk drug analysis [99], 
benzylpenici l l in determination by capil lary zone 
electrophoresis [100] and a collaborative study of 
determining penicil l in V in tablets [101]. 
Several papers have described the use of enzyme selective 
electrodes for determining penici l l ins [102-103] . The effect 
of pH and buffer concentrat ion on the response of an enzyme 
membrane coated wire electrode is also described [102]. 
Spectrophotometr ic methods continue to enjoy populari ty for 
the determination of a variety of penici l l ins . The first 
derivative mode of operation is found to be simple, 
accurate , and precise for the determination of amoxycil l in 
and clavulanic acid in pharmaceutical preparat ions[ 104]. 
Second derivative spectroscopy has been applied to 
quanti tat ion of ampicil l in and dicloxaci l l in [105], & 
ampicil l in and cloxacil l in [106]. Both method by Morelli are 
suitable for the analysis of these P-lactums in 
pharmaceut ical preparat ions. A forth-derivative spectro-
scopic approach has been described for the determination of 
4-hydroxyphenoxymethylpenici l l in in phenoxymethyci l l in 
samples [107]. A second derivative spectroscopic method 
described the determination of ampicil l in & cloxacil l in 
[108]. The method consists of dissolution of the formulation 
in water followed by scanning the spectra between 260 nm 
and 330 nm. Derivative measurements are obtained at 269nm 
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and 284nm for ampicill in and cloxacil l in respect ively. The 
hydrolysis of ampicill in and cloxacil l in followed by direct 
spectrophotometr ic determination at 273nm has been 
described [109]. The method is found to be specific to 
ampicil l in in the presence of cloxacil l in & linear from 5-35 
|j,gmL"'. 
A variety of techniques have been evaluated for the 
quantif ication of amoxycill in alone or in combination with 
other penici l l ins [1 lO-l 12], Micellar electrokinetic capillary 
chromatography has been found to be a useful approach for 
identifying degraded products in aged amoxycil l in [110]. In 
addit ion, the reaction of amoxycil l in with acetylacetone-
formaldehyde has served as the basis for a simple 
spectroscopic method [111]. Beer" law is obeyed from 10-
100)j.gmL"', and no interference is observed in mixtures 
containing cloxacil l in excipients . The simultaneous 
flourometric determination of amoxycill in and clavulanic 
acid is possible using a stopped-flow kinetic approach 
[1 12]. The method involves the reaction of the analytes with 
acidic Ce (IV) and detection at ' '365nm. Another 
spectroscopic method for the ampicil l in is carried out using 
ni t robenzene as colorimetric reagent [113]. An 
electrochemical method for quantifying P-lactum antibiot ics 
and their hydrolysis products is described [114]. Cyclic 
voltametry at the water /ni t robenzene interface in four 
electrode system is used. Hydrolysis products are 
character ized across UV- vis spectrum. 
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Diclofenac sodium 
Diclofenac sodium is the most commonly used, non-steriodal 
ant i- inflammatory drug. It has potent analgesic, antipyretic 
and anti- inflammatory actions, with minimum adverse 
effects. It is an ideal drug for anthrit ic pateints , requiring 
long term therapy. Rheumatic conditions are recalci trant 
disorders which cause immense anxiety, loss of mobili ty, 
dexteri ty and sleep to its pat ients , even leading to 
depressions. Non-steriodal anti- inflammatory drugs 
especial ly the sustained release forms have proved to be 
highly efficacious in tackling chronic rheumatoid condit ions 
associated with pain and inflammations. In chronic 
condit ions, patient compliance's assume a critical role 
especial ly where prolonged drug treatment is required. The 
challenge to the pharmaceutical industry is to developed 
dosage forms that ensure once daily dosing while 
maintaining steady and constant therapeutic level of the 
drug within the pat ient ' s system. 
Different analytical methods have been reported in the 
scientific l i terature for the determination of diclofenac in 
plasma, urine, synovial fluid and pharmaceutical 
preparat ions . Several anti- inflammatory drugs including 
diclofenac have been quantified in different dosage forms by 
capil lary zone electrophoresis and micellar electrokinetic 
capi l la ry 'chromatography [115]. The experiments have been 
performed without specific sample pretreatment . The 
samples are directly dissolved in the running buffer and the 
internal standard method has been used for assays with 
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respect to standard solutions. Diclofenac with other drugs 
has been determined by flow injection analysis with 
spectrophotometr ic detection [116]. The method has offered 
good advantage with respect to short start-up time, 
simplicity of instrumentat ion & high sampling rate. The 
spectrophotometr ic determination of trace amounts of 
diclofenac has been carried out by l iquid-l iquid extraction 
using arcidine yellow with a flow system [117]. The 
determinat ion of diclofenac in the range of 3-80}4.mgL'' is 
achieved with a sampling frequency of 40 sample h' . The 
spectroflourometric determination of diclofenac in 
pharmaceut ical tablets and ointments has been described 
[118]. It involves excitat ion at 287nm of an acid solution of 
the drug, and measurement of the fluorescences intensity at 
362nm. A second derivative spectrophotometr ic method has 
been developed [119] for the determination of degraded 
products of diclofenac sodium in gel ointment. The 
ampli tudes in the second derivative spectra at 260nm and 
265nm are selected to determine oxidol. The diclofenac and 
codeine phosphate in diclofenac tablets has been determined 
[120] by RP-HPLC at the wavelength of 250nm. Another RP-
HPLC method for the simultaneous estimation of diclofenac, 
paracetamol & chloroxazone in formulations has been 
described [121]. The method is carried out on zorbax C8 
colunm at the detection wavelength of 220nm. 
Spectrophotometr ic methods for the determination of 
diclofenac in pharmaceutical preparat ions have been 
described [122]. The methods are based on the oxidation of 
drug using reagents viz; eerie ammonium sulphate, 
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dibromodimethylhydant ion, N-bromosuccinimide & 
potassium bromate to yield coloured products with maximum 
absorbances at 450, 385, 385 and 495nm respect ively. 
Diclofenac sodium in Ganmaotong tablets has been 
determined by first derivative spectrophotometry [123] at 
292nm. A simple and precise HPTLC method has been 
developed for the simultaneous determination of diclofenac 
and paracetamol [124]. Voltametric propert ies of diclofenac 
sodium on the glassy carbon electrode have been described 
and the determination concentrat ion of diclofenac with 
differential pulse voltmetry are revealed [125]. The 
sensit ive anodic current of diclofenac sodium on 0.93V is 
observed. Diclofenac sodium in Ganmaotong tablets has 
been determined by forming a green complex with copper 
acetate in chloroform in a specified pH range [126]. 
Diclofenac sodium also has been determined in dosage forms 
[127] by spectrophotometry based on the formation of 
ni troso derivatives followed by alkal inizat ion to yield a 
stable yellow chromophore which exhibits A-max at 378nm. 
C i s a p r i d e 
Cisapride is a benzamide and a recently developed 
prokinet ic drug. It decrease receptive relaxation in the upper 
portion of stomach and increases antral contract ions . The 
pylorus and duodenum are relaxed, while the tone of the 
lower esophageal splinter is enhanced. These effects 
combine to accelrate the emptying of gastric contents and to 
reduce reflux from the duodenum and the stomach into the 
esophagus. Cisapride is believed to increase colonic motility 
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and can cause diarrhea. The prokinetic action of cisapride is 
blocked by atropine and may involve the release of 
myenteric acetylcholine. Cisapride appears to be devoid of 
dopaminergic blocking activity and it does not influence 
the concentrat ion of prolactin in plasma or cause extra-
pyramidal symptoms. Recently some reports of serious 
ventr icular arrhythmia's and death have appeared among 
patients who took antifungal/macrolide ant ibiot ics while on 
cisapride. Blood level of cisapride was raised due to 
inhibi t ion of CYP 3A4 by erythromycin, ketoconazole etc. 
Used alone has not caused such arrhythmia 's . A warning has 
been issued to use cisapride cautiously in patients receiving 
macrol ides / imidazoles. 
Cisapride has been always determined in dosage forms and 
biological media. An HPLC method is described for the 
quanti tat ive analysis of cisapride in human plasma [128]. 
Cisapride together with internal standard are analysed 
isocrat ical ly on a reversed phase column and eluted drugs 
are detected with UV-Vis detector at 276nm. A stability 
indicat ing HPTLC method is used for the determination of 
cisapride and related impurit ies in tablets [129]. Beer ' s law 
follows in the concentrat ion range 2.5-15 j imgL' ' . A single 
dose crossover study of two conventional formulations of 
cisapride tablets is carried out in twelve healthy human male 
volunteers [130]. Blood samples are collected at time 
intervals and plasma cisapride is determined using RP-HPLC 
with UV detection. Three spectrophotometr ic methods (A-C) 
for the assay of cisapride in pure and dosage forms are 
described [13 1]. Method A is based on coupling reaction of 
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cisapride with 3-methyl-2-benzothiazol inene hydrazone-HCl 
in presence of FeCh to form a coloured species with X-max. 
at 565nm. Method B is based on the oxidation of cisapride 
with Fe^^ and subsequent chelation of Fe "^^  with 1,10-
phenanthrol ine. Method C is based on the formation of a 
coloured charge transfer complex with chlorani l ic acid 
having Xmax at 555nm. Another reversed phase liquid 
chromatographic method is reported for the determinat ion of 
cisapride in pharmaceutical dosage forms [132]. A method is 
also proposed [133] for the polarographic determinat ion of 
cisapride in which the electroactive product is obtained by 
ni t rat ion with potassium nitrate in sulphuric acid. The 3s-
detection limit is 1.8x10" M and the relat ive standard 
deviation is 1%. 
N a l i d i x i c acid 
Nalidixic acid is an antibacterial agent that has been 
extensively used in the treatment of Gram-negative urinary 
tract infections. It is commercially available for the 
medicinal use and has also found application as an effective 
aid in the control of chicken infection. Nal idixic acid 
inhibits the replication of DNA in bacteria, without 
immediately affecting RNA or protein synthesis in sensit ive 
bacteria. Its toxic effects in animals are limited to inhibit ing 
mitochondrial DNA replicat ion at concentrat ions that do not 
affect nuclear DNA. Nalidixic acid being a synthetic drug is 
excreted together with inactive metaboli tes , in the urine. It 
is bacter icidal to most of the Gram-negative bacteria that 
cause common urinary tract infections, except for 
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pseudomonas strains. Resistance to nalidixic acid develops 
readily but is apparently not transferable from one organism 
to another. 
Nal idixic acid is given orally because it is absorbed from 
the gastrointest inal tract. A large proportion of the drug is 
bound to plasma proteins and penetrat ion into the tissue in 
poor. The plasma half-life is about 1.5 hours, and the major 
route of excretion of both parent compound and metaboli tes 
is via the kidney. The metaboli tes of nal idixic acid are 
bacter iological ly inactive, but sufficient unmetabolised 
compound is excreted into the urine to make nal idixic acid 
useful in the treatment of urinary tract infections. The toxic 
effect of nalidixic acid include nausea and vomit t ing, skin 
rashes and photosensi t ivi ty reactions and central nervous 
system effects such as dizziness and visual disorders. 
Nalidixic acid can displace warfarm from protein binding 
sites and can prolong the clotting time, or cause 
naemorrhage, if these drugs are given together. From 
analyt ical point of view several methods have been proposed 
for the assay of nalidixic acid in biological samples and 
commercial formulations. The luminescence character is t ics 
of the inclusion complex of nalidixic acid with y-
cyclodextr in has been investigated [134]. The study involves 
the characterizat ion of inclusion process involved and 
development of a spectroflourimetric method for the 
determinat ion of this drug. The calibrat ion range has been 
found to be 0.1-2.0 ngmL' ' . A TLC procedure has been 
developed for the quanti tat ive monitoring of the degradation 
of nal idixic acid in solutions irradiated with high pressure 
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mercury lamp [135]. High performance TLC combined with 
densi tometry enabled accurate and reproducible quanti tat ion 
of nal idixic acid in the presence of its degraded products . 
Another HPTLC method has been described for the 
simultaneous determination of nalidixic and metronidazole 
in pharmaceutical preparat ions [136]. Linear response is 
observed in the range of 20-120ng and 40-140ng for 
metronidazole and nalidixic acid and respect ively. Capillary 
e lectrophoresis has been applied to the separation of 
nal idixic acid and other quinolones of first and second 
generation [137]. The same system is applied for the 
quanti ta t ive determination of these quinolones in tablets and 
capsules without specific sample pretreatment. An HPLC 
assay for nalidixic acid has been developed. Reverse- phase 
chromatography [138] is conducted using mobile phase of 
ammonium acetate, methanol & acetronitr i le and detection at 
254nm. 
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I n t r o d u c t i o n 
A large number of methods for the analysis of ampicil l in, 
amoxycil l in and cloxacil l in and related antibiot ics are 
described [1-3] . Emphasis has been given on 
spectrophotometr ic and t i t r imetr ic methods, because they 
are simple and easily manageable to the third world. The 
volumetr ic t i t rat ions are carried out by some oxidants prior 
to a base or acid catalysed reaction of ant ibiot ics . The 
degraded hydrolyzed products of ant ibiot ics are t i trated 
quanti tat ively against oxidants such as Hg "^^  [4] and iodate 
solut ions [5]. It is observed that when hydrolyt ic condit ions 
are changed from moderate concentrat ion of alkali or acid to 
a weak or using the selective pH region [6] , a different 
pathway of antibiotics mechanism results . The t i t r imetr ic 
method [4] described by alkaline or enzymic hydrolysis 
followed by ti tration with Hg(l l) might suffer a setback. The 
use of nitric acid to neutral ize the excess alkali before 
performing the t i trat ion may oxidize thiozol idine ring of the 
penici l l in molecule and therefore could give erroneous 
resul ts . The authors themselves reported better results with 
enzyme hydrolysis than base hydrolysis . 
In direct t i tration of antibiot ics [5], with potassium iodate 
solution, strong acidic condit ions are prevailed. The acid 
plays a ,dual role, first it brings about acid hydrolysis , 
secondly it makes quanti tat ive oxidation t i t rat ion feasible. 
Two procedures are adopted [5]. In the first, the end point is 
detected by a colour change in carbon tetrachloride layer 
from colourless to brown or deep red and in the second dye 
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Amaranth is used to detect change in colour from deep red 
to pale yellow, as the drug is destroyed by an excess of 
iodate in aqueous medium at the neutral izat ion point. 
The determination of amoxycil l in and flucloxacil l in in 
mixtures and pharmaceutical preparat ions using 3,5-dinitro-
benzoic acid as a reagent is described [7] . Extractive 
spectrophotometr ic determination of benzylpenici l l in is 
described in pharmaceutical preparat ion, based on the 
formation of a yellowish red colour with potassium iodate in 
acidic medium [8]. The colour is stable for half an hour and 
Beer's law is obeyed in the concentrat ion range 0.05-0.5 
mgmL"'. Another such method for benzylpenici l l in sodium 
in 10% potassium nitrate solution containing sulphuric acid 
involves a colour reaction with 2 ,3 ,5- t r iphenyl te t razol in 
chloride [9]. The coloured product in extracted with 
enthanol having ^tmax. 400nm. A selective colorimetr ic 
method is described for the analysis of ampici l l in in its 
reaction with p-dimethylaminocinnamaldehyde in the 
presence of te t ra-chloroacet ic acid to form a stable red 
sch i f f s base [10]. The coloured product is detected at 
Xmax. 501nm and obeyed Beer's law in the range 10-50 
/.igmL. The formation of deep blue complexes are utalized 
for the micro-quant i ta t ive determination of ampicil l in and 
cloxaci l l in in pure form, mixture and in pharmaceut ical 
preparat ion [11]. The reaction is carried out with 
bromothymol blue (BTB) at 25°C and 50°C respect ively. 
Beer's law is valid in the concentrat ion range 0.4-18 and 
0.4-20 mgmL' of ampicil l in and cloxacil l in respect ively. 
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The determination of amoxycil l in and f lucloxacil l in by 
HPLC in biflocin injection is described [12]. The mobile 
phase is phosphate buffer (pH-6.5) and the valid 
concentrat ion range is 0.25-2.0 mgmL•^ Another HPLC 
method is carried out for the simultaneous determination of 
ampicil l in and dicloxacil l in in pharmaceutical preparation 
[13]. The complexation of amoxycil l in and carbocystein 
with Ni(I l ) is used for spectrophotometer ic determiantion 
[14]. A flow injection analysis is described for the 
determinat ion of amoxycil l in and ampicil l in [15]. 
Ti t r imetr ic method for the assay of selected ant ibiot ics in 
non-aqueous media is carried out by conductometeric 
t i t rat ion [16]. A spectrophotometr ic method for the 
simultaneous determination of amoxycill in and dicloxacil l in 
in pharmaceutical preparat ions is described [17]. The assay 
of ampici l l in in presence of cloxacil l in in pharmaceut ical 
preparat ions , which involves the reaction of hydrolysed 
ampicil l in with fromaldehyde in acidic phosphate and 
subsequent measurement of the absorbance at 373nm is 
described [18]. Copper( l l ) acetate has been 
used as a complexing agent for the spectrophotometr ic 
determinat ion of benzylpenici l l in in pharmaceutical 
preparat ions [19]. 
In this chapter, we described the base catalysed hydrolysis 
of ant ibiot ics in dilute sodium hydroxide solution. 
The hydrolysis product of antibiot ics which contains 
sulphur derivatives e.g., -C-S-C group, -S-H group are 
quant i ta t ively oxidized to sulphonic acid by t i t rat ing them 
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against potassium iodate solution as oxidant, in dilute 
hydrochlor ic acid to prevail conducive atmosphere of pH~ 2. 
The chemistry of this reductant system is described which 
shows the observed stoichiometr ic value of thiol group to 
iodate 1:2, which is consistent with theoret ical value. The 
point of difference of our finding to that of previously 
described by Andrews ti tration [20] have been high-l ighted. 
The volumetric results are compared to spectrophotometr ic 
determinat ions . The pathway and the oxidation mechanism 
of hydrolysis products of antibiot ics have been proposed in 
the light of IR, TLC and spectrophotometr ic s tudies. 
EXPERIMENTAL 
Reagents: All the experiments were performed with 
analytical reagent grade chemicals using double dist i l led 
water. Stock solution of ant ibiot ics , ImgmL"' were prepared 
by dissolving the pure and standard drugs in water and 
stored in a well-dark and closed container to avoid direct 
contact with light. Hydrochloric acid standard solution 
( l .OM), potassium iodate and sodium hydroxide of O.IM 
each were prepared in disti l led water. 
Apparatus: A Bauch and Lomb spectronic-20D'^ and 
spectronic-1001 spli t-bean spectrophotmeter (Milton Roy 
Co.) with 1cm path length quartz cells and a controlled 
temprature water bath (NSW-133 India) were used. IR 
spectra of the isolated products were recorded on a 
spectrometer (Shimadzu IR-408, Japan) with KBr disc. 
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Procedure I:- S imu l t aneous determination of Antibiotics 
by volumetric titration against potassium iodate and 
spectrophotometry of coloured complex in organic layer. 
Aliquots of 2.5 mL of O.IM sodium hydroxide were added 
into conical flasks followed suitable volumes of each of the 
standard antibiotic solutions, ranging between 0.2-2.0mL of 
amoxyci l l in , ampicil l in, carbenici l l in and Becampici l l in , 
0.1-2.5mL cloxacil l in and 0.2-2.3mL of benzylpenici l l in . 
The contents were shaken and placed in a water bath at 80°C 
for 10-1 Sminutes. After completion of the heat treatment, 
the mixture was cooled to room temperature, followed by 
0.5mL of O.IM hydrochloric acid and 5mL carbon 
te t rachlor ide . The mixture content were t i trated against 
potassium iodate with intermittent shaking till the colour 
changed from colourless to deep red in non-aqeous layer. 
For sepctrophotometr ic determination, the non-aqueous 
coloured layer was removed using 50mL separat ing funnel 
and dried over sodium sulphate. Absorbance was measured 
at 520nm against the blank, containing all the species 
except drug. This was the idea behind simultaneous 
determinat ion, that is performing two different methods at a 
time in the same mixture content. 
Procedure II: Determination of Antibiotics by Spectro 
photometric method . 
To a known volume of antibiotic solution ranging 
between amoxycill in (0.4-3.5mL), ampicil l in (0.4-2.8mL), 
c loxaci l l in (0.1-2.5mL), benzylpenici l l in (0.1 -2.9mL), 
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carbenici l in (0.2-2.3mL) and becampici l l in (0. l -2 .4mL), 2.5 
mL of sodium hydroxide was added in a conical flask. The 
reaction mixture was kept for 10-15min.on a water bath at 
80°C. After cooling to room temperature , l.OmL of 
potassium iodate, 0.5mL of hydrochloric acid and 5mL of 
carbon tetrachloride were added to the reaction mixture. The 
solution was shaken vigorously till a deep red colour was 
obtained in organic layer. It was determined 
spectrophotometr ical ly by the recommended procedure 1. 
Dosage forms: Tablets & Capsules 
Twenty tablets were weigh ed and grinded to a fine powder. 
An accurately weighed portion of this powder equivalent to 
lOOmg is taken in a lOOmL standard flask. Similarly the 
contents of the capsules were weighed and dissolved 
equivalent to lOOmg in 0.1 l i tre. The mixture was shaken for 
about 30minutes to ensure a homogeneous solution. The 
residue was removed through whattman No . l filter paper and 
the washing were taken into final volume of 0.1 l i tre. 
R E S U L T S AND D I S C U S S I O N 
Mechanistic approach: 
This involves UV,1R, TLC and molar s toichiometric studies. 
The hydrolysis of ant ibiot ics is catalysed by a base using 
O.IM sodium hydroxide solution at pH~13 in a single stage 
reaction. It is carried out in a water bath at 80°C for 15 
minutes with intermittent shaking result ing in different 
degraded products which contain sulphur derivat ives, e.g 
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-S-S-(disulphide) and -S-H(thiol) groups. These degraded 
products when subjected to redox ti tration against potassium 
iodate as oxidant in dilute hydrochloric acid solution, they 
are quanti tat ively converted to sulphonic acid with 
some intermediate species viz; penici l lenic acid(IIb) and 
sulphoxide(IIIb) . The degradation pathway is more precisely 
i l lustrated in figure 2 3 -
The results obtained by performing thin layer 
chromatography(TLC) with Rf = 0.46 in solvents (v/v) 
comprising, 66% n-butanol, 17% glacial acetic acid and 17% 
water, suggested the presence of 4-hydroxymethylene 
oxazolone. This observation is in agreement with previous 
studies [6], which confirms the existence of la, (Rf = 0.42 in 
the same solvent system). Our studies of the degraded 
products of penici l l ins at pH~13 involving a single step 
reaction using water bath at 80°C for 15 minutes show one 
Xmax at 240nm. This at tr ibutes the existence of one of the 
three species viz; Ib(i) or Ib(ii) or Ib(i i i) . Moreover the 
formation of penici l loic acid Ib(i) from basic hydrolysis of 
penici l l in is well established [21]. Another Xm&x at 270nm 
is obtained when time interval is extended to 12 hours, thus 
confirming the establishment of 1(a). The previous studies 
show the existence of 1(a) as a degraded product of 
ant ibiot ics in the pH range 13-14 with UV spectroscopic 
analysis showing Xmax at 297.5nm. The slight difference in 
the Xmax. value may be at tr ibuted to different experimental 
condit ions of hydrolysis , such as temperature , time of 
hydrolysis and pH etc. 
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To carryout IR studies of ant ibiot ics , three different spectra 
were taken for, 
(i) Pure amoxycil l in, Spectrum-A (Fig.2.4) . 
(ii) Degraded in base catalysed hydrolysis , Spectrum-B 
(Fig. 2.5) 
(i i i) Degraded base hydrolysed products t reated with O.IM 
hydrochlor ic acid followed by t i trat ion against KIO3, 
Spectrum-C (Fig. 2.6). 
The comparison of spectrum (A) and (B), revealed that the 
character is t ic bai>ds for different groups at specified 
frequencies in spectrum (A) are found (i) missing, (ii) the 
formation at different frequencies or (iii) remained 
unchanged. A broad flat portion (3450-2600cm"') same as it 
was found in spectrum (A), at tr ibuted to primary al iphatic 
amine N-H (3450-3250cm"') , carboxylic (3300-2500cm"') 
and S-H (2600-2500cm' ' ) groupings. 
The bands are found missing in the range (1800-1500cm"') 
and 1350-lOOOcm"') result ing the formation of bands at 
860cm"', 680cm"' and in the range (1500-1350cm"') . The 
identi t ies of thiozoiidine and secondary amine groups with 
different group frequencies lying in the range (1800-
1510cm"') are completely swept out. The second range of 
missing band (1350-1000cm"') includes the groups e.g. CH3-
S, ester etc. The two missing ranges are revealed by a 
descending and ascending portion of spectra-B respect ively. 
The formation of a broad band (1500-1350cm"') is at tr ibuted 
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to the presence of 4-hydroxymethylene oxazolone ( la) , 
which is revealed by the group frequency C-0 stretching and 
0-H deformation vibration (1440-1395cm' ' ) . The ascending 
portion (1350cm"' onwards) of spectrum-B further describes 
the hydrolysis of rest of the groups present. A strong peak at 
860cm"' may be at tr ibuted to S-0 (870-810cm"') of 
sulphonic acid. The peak at 680cm"' suggests to disulphide 
-S-S, C-S (705-570cm' ' ) and sulphoxides (>S=0, C-S-0 at 
730-690 c m ' ) after their partial oxidation to sulphonic acid 
in semiquanti ta t ive manner as the sulphur compounds 
especial ly containing the group S-H, S-S are oxidized by 
mild oxidant or even atmospheric oxygen [22]. The spectrum 
-C, which is obtained after completing the t i tration against 
iodate in dilute acidic condit ions, gave the final product 
corresponding to strong peak at 835cm' ' , a t t r ibuted to the 
presence of sulphonic acid quanti ta t ively. 
The recommended procedure 1 describes s imultaneous 
volumetr ic determination of penici l l in against potassium 
iodate as oxidant in dilute acid medium. The deep-violet 
colour extracted in carbon tetrachloride at the equivalence 
point is stable for two hours and has been studied 
spectrophotometr ical ly . The hydrolysis product of 
ant ibiot ics which contained sulphur derivatives i.e., -C-S-C 
(lb), -S-H groups are quanti tat ively oxidized to some 
intermediate species and finally to sulphonic acid whose 
identi t ies have already been discussed in IR studies . The 
hydrolysis by dilute sodium hydroxide solution has been 
carried out slowly at a constant temperature 80°C with 
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intermit tent shaking. The excess of base is neutral ized by 
adding hydrochloric acid (0.5 mmoles) so that the reaction 
mixture attains a pH~2. This provides a conducive 
environment of HjO^ion concentrat ion for carrying out 
quanti tat ive t i tration of degraded products against potassium 
iodate. The reaction is summarized as follov/s; 
6Q 
HS-R+3H2O -• RS03H+6H'+ 6e"] x 2 Step I 
I0"3 + C1" 6 H ' +4e" > ICI + 3H3O'] x3 
In the first step reaction a quanti tat ive oxidation of thiol to 
sulphonic acid followed by reduction of IO3' to ICI takes 
place which may be regarded as the reaction at equivalence 
point, but without any colour change. This shows that the 
s toichiometr ic value calculated theoret ical ly should be of 
2mol. of thiol group to 3mol of iodate (1:1.5) which is 
inconsis tent with experimental value 1:2 [23]. However, the 
system still involves more iodate ions to make the end point 
visible due to its reduction to iodine monochloride and 
finally to free iodine. This is described in step II reaction 
^3^.4c«pT;«^d diagramatical ly: 
"^"^""^ ''" IO3(+5) mdilute HCl 
reduction 
10-3 + Cr + 6Fr+4e ^ ICI+3H2O Step II 
M:55Q9 '^ 
Quantitafttese oxitfiltrbn 
ot penicillin 
PenecillinIOi(l 1 5) 
-. i ; 
i  ^^  JpWr^nd point 
Increases 
True end point 
Penicillin 10", (1 ly 
ylCU+l) 
• More IO3 involeved in theSyite*-.. 
Overconsuniption of IO3 
'^ I: (0 00) 
Fig .2 .1 . Over consumption of iodate at the end pt. in 
recommende^d procedure. 
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iCl 
dissociation 
-> I'+cr 
hydrolysis 
> H O l + H " r+HsO 
over consumption , 
5 H 0 I • 2 l 2 + IO-3 + H " + 2 H 2 0 
of iodate 
In the step II, an overconsumption of iodate takes place 
[24], thereby increasing the mole ratio of iodate from 1.5 to 
2mol which is consistent with the exper imental ly observed 
stoichiometry of Imol thiol to 2mol iodate. A stable red 
violet colour of free iodine in organic layer indicates the 
equivalence point. It is observed that further addition of 
iodate solution beyond the end point results no 
decolourizat ion in mixture content. This means that a 
quanti tat ive oxidat ion-reduct ion in dilute hydrochloric acid 
has taken place in the system. The titrant iodate is reduced 
first to iodine monochloride and finally to free iodine to 
show a visible end point. The E° of iodate in dilute 
hydrochloric acid (1.19V) is less than the E° in Andrews 
t i trat ion (1.23V). The E° (1.19V) is high enough to oxidize 
the degraded products of antibiot ics containing derivat ives. 
In Andrews t i trat ion strong hydrochloric acid (3-9M) 
solution is required for reduction of iodate to iodine 
monochloride (ICI2") complex. 
Penicillin complclely consumed -4 
10-3 (+5) Strong HCl (3-9 M) 
IO"3+6H*+2Cr+4e" ^ IClz+SHaO 
E° = 1 23V 
T IC1'2(+1) 
In presence of penicillin 
• 12(0 00) 2ICl"2+2e- ^ I2+4CJ-
£"= I06V 
Figure 2.2 Andrews t i t rat ion 
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During the course of t i trat ion with reducing agent, the 
presence of free iodine in the system also results from the 
further reduction of ICI2' complex as given above. When the 
reducing agent has been consumed, the free iodine is t i trated 
to form iodine monochloride complex. The end point is 
marked by the disappearance of the last free iodine. (A point 
of difference from our observation given in Step II). 
2I2 +IO".v + 6H"+ lOCr -> 51Cr2+3H20 
The above conditions prevail , if the concentrat ion of the 
hydrochlor ic acid at the end point is at least 3M. The iodate 
reacts quanti tat ively with reducing agents such as Kl,l2, 
AS203,N2H4 and SO2 to iodine monochloride [25]. In many 
other cases the concentration of hydrochloric acid is not 
cri t ical , but for Sb( l l l ) , it is 2.5 to 3.5M; that is the 
optimum acidity for reasonably rapid reaction varies from 
one reactant to another reactant [20] . 
The recommended procedure 1, which describes the use of 
dilute hydrochloric acid is applied successfully to the 
simultaneous quanti tat ive reduction of iodate to free iodine 
at the equivalence point, especial ly in a system which 
contains the degraded products of ant ibiot ics with sulphur 
derivat ives which can be oxidized by very mild oxidizing 
agents [22] . The half reaction of iodate in dilute acid 
solution with E° [25] can be proposed as under. 
2IO"3 + 12H"+10e" -^ I2 + 6H2O E° = 1.19V 
The method described earlier [5] for the direct t i t rat ion of 
ant ibiot ics by iodate solution in a high concentrat ion of acid 
is based on Andrews method. The reduction of iodate to 
iodine-monochlor ide complex involving electron change of 
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four and oxidation of thiol group from penici l lamine (IV) to 
sulphonic acid(VI) and that of aldehyde from 
peni l loaldehyde (111) to the carboxylic acid(V) are 
accompanied with electron changes of six and two 
respect ively. 
The overall s toichiometry has been computed by summing 
up two oxidation products with a total electron change of 
eight which is consistent with their experimental 
s toichiometr ic ratio 2mol iodate and Imol penici l l in . This is 
revealed by the following react ion: 
Penicill in + [V] +[V1] + 8e" 
10"3 + 6 H ' + 2 C r + 4e" -^ ICl'z + 3H20]x2 
However, if the above oxidation reduction is considered 
separately it reflects a different aspect as given below: 
H-S (IV) -> H03S"(Vl)+6e"]x2 
I0"3 +4e" -» I d s ' ] X 3 (i) 
-CHO (111) -^ COOH (V) + 2e"]x2 
I0 '3 + 4e" ^ I C l 2 " ] x i (ii) 
In reaction (i), the stoichiometry of 2mol penici l l in /H-S to 
3mol iodate and in (ii) 2mol penici l l in/-CHO to Imol 
iodate are observed, which is inconsistent with their 
experimental ly stoichiometric ratio of iodate to penici l l in 
2 :1 . 
We have tried to elaborate the above reaction system taking 
place in two fold manner i.e. potassium iodate is reduced to 
iodine monochloride in the presence of high concentrat ion 
of acid (12moldm' ' ' ) . During the cource of t i t rat ion as long 
as the reductant is present in the system, iodine 
monochloride is further reduced to free iodine. The stage of 
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titration can be regarded as the first step, when equivalence 
point can be declared theoretically which immediately 
vanishes due to further reaction of iodine with iodate. The 
second step of titration is started with free iodine to yield 
iodine monochloride complex, the disappearance of deep red 
violet colour to colourless resulting the declaration of 
equivalence point, followed by an over consumption of 
iodate which increases the number of moles of iodate, 
approximately to experimental value. 
The effect of interfering substances in the determination of 
penicillin are shown in Table2.7. This study shows the 
maximum tolerance of interfering substances in the 
minimum amount of penicillin. The validity of the proposed 
method was tested by successive determination of penicillin 
in pharmaceutical preparation. The results obtained by the 
recommended method are presented in table2.8. The 
treatment of analytical data using statistical approach for 
the determination of all the penicillins using different 
concentrations have been presented in Table2.9. The best 
straight line equation with variables x and y and 
incorporating the slope and intercepts for each antibiotic is 
computed. 
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Chapter-3 
ShBctrohhotometrk Ueferminafion of 
Dkfofenac Sodium in Urua "Tormufations. 
no 
Introduction: 
Diclofenac sodium is the sodium salt of [o-(2,6 
dichloroanilino) phenyl] acetic acid and is an antipyretic, 
analgesic&well-tolerated non-steriodal anti-inflammatory 
agent with potent activity in the treatment of rheumatic 
diseases. The assay of diclofenac sodium is carried out by 
most of the analytical techniques. A method for the 
simultaneous determination of diclofenac sodium and its 
hydroxy metabolite has been described [1] by cappillary 
column gas chromatography with electron capture detection 
which follows extractive alkylation. The method is also 
applied to analyze urine samples of volunteers treated with 
single doses of diclofenac sodium. A high performance 
liquid chromatographic assay has been proposed [2] for the 
determination of a number of anti-inflammatory drugs 
including diclofenac in plasma. The samples in this method 
are prepared by adding acetronitrile and perchloric acid to 
200).iL plasma. Diclofenac sodium with other drugs is 
quantified in the supernatant procedure using a mobile phase 
of perchloric acid-acetronitrile and a detecting wavelength 
of 254nm. The method is also applied to the cross -sectional 
study of medication compliances. Another sensitive HPLC 
procedure for the assay of diclofenac and its 
monohydroxylated metabolites in biological fluids has been 
described [3]. Diclofenac is assayed in plasma at 
concentration down lOngmL'', while in combination with its 
monohydroxylated metabolites it is assayed in urine, after 
chemical analysis at concentration down to 200 ngmL"'. A 
liquid chromatographic method has been developed [4] for 
I l l 
the determination of diclofenac and related materials in 
formulations and raw materials. The method resolves ten 
related compounds with limits of quantitation 0.2% or less. 
Pharmacokinetics of diclofenac sodium has been also 
studied [5] by developed high performance liquid 
chromatography in serum and urine using acetaminophen as 
internal standard, a reversed phase C-18 column and 
ethanol: water as mobile phase. A spectroflurometric 
determination of diclofenac sodium in bulk and 
pharmaceutical preparations has been described [6]. The 
method is based on the hypersensitive property of the 
fluorescent probe ion Eu""^ , at 616nm. The interaction with 
diclofenac, which contains a carboxylic group, makes the 
transition allowed and enhances the intensity of its 
flourescence emission. A spectrophotometric method based 
on the fixation of diclofenac on sephadex QAEA-25 resin as 
solid phase has been described [7]. The absorbance of solid 
phase is measured at 281nm and 400nm. A multifactor 
optimization techniques has been successfully applied to 
develop new spectrophotometric method in which diclofenac 
is analysed and determined as its Fe(III) complex [8]. A 
four-variable two level factorial design is used to 
investigate the significance of each variable and interaction 
between them. A colorimetric method for the determination 
of diclofenac sodium is based on the formation of coloured 
charge-transfer complex with chloranil [9]. The complex is 
formed in EtOH showing Xmax. at 545nm and concentration 
ranges between 0.08-0.9 mgmL''. Another charge-transfer 
study of diclofenac for its determination has been carried 
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out with p-benzaquinone and chloranil [10]. In ehtnol 
medium the reaction occurs readily with p-benzaquinone, 
while the reaction with chloranil is feasible in alkaline 
medium. Spectrophotometric methods for the determination 
of diclofenac sodium in its formulations have been described 
[11]. The first method involves the oxidation of drug studied 
by ammonium persulphate in alkaline medium and coupling 
with dimethylaminobenzaldelyde reagent. The resultant 
solution is a yellow coloured product with its analytical 
wavelength at 450nm. In second method the diclofenac has 
been treated with sodium hypobromite in presence of 
cetrimide in alkaline medium. The yellow coloured solution 
is determined colorimetrically at 460nm. Another 
spectrophotometric method has been described [12]which 
involves the treatment of diclofenac with sodium nitrite in 
presence of hydrochloric acid, producing a yellow colour 
having /\,max. at 390nm. Two more spectrophotometric 
methods have been described [13] for the determination of 
diclofenac sodium. In the first method diclofenac reduces 
Iron(III) to Iron (II), which subsequently forms complex 
with 2,2-bipyridine. The chelate complex formed posses 
maximum absorbance at 520nm. In the second method the 
diclofenac forms ion pair complex with methylene blue in 
presence of phosphate buffer which is extracted with 
chloroform. The complex formed shows maximum 
absorbance at 640nm and the graph of absorbance versus 
concentration is linear in the range 5-40^lgmL"^ An 
extractive spectrophotometric determination of some anti-
inflammatory 4rugs including diclofenac in pharmaceutical 
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preparations has been described [14]. It is based on the 
formation of a chloroform soluble ion-association complex 
between the drugs studied and methylene violet at pH~7.6. 
The present work describes the colorimetric methods for the 
determination of diclofenac sodium in bulk and commerical 
dosage forms. In first method determination is achieved 
through the formation of stable donor-acceptor complex with 
chloranilic acid. The resulting intensely reddish chloranilic 
acid radical anion possesses a characteristic absorption 
maximum at 530rm. The second method is based on the 
reduction of Iron(IIl) by diclofenac and subsequent 
complexation of Iron(II) with 1, lO-phenanthroline, having 
maximum absorbance at 500 nm. The possible interferences 
by various excipients have been checked out. Application of 
the suggested methods to representative dosage forms are 
presented and compared with the reference method. 
E X P E R I M E N T A L 
Apparatus Method-I 
A Spectronic-20D^ (Split-beam Milton Roy Co) 
spectrophotometer, with Icm path length quartz cell was 
used. 
Reagents 
All reagents used were of analytical-reagent grade and the 
solvent of spectroscopic grade. A 0.1% chloranilic acid 
.solution in 1,4-dioxane and the diclofenac sodium solution 
of ImgmL'' concentration in methanol were used. 
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General procedure for the calibration: 
-1 Accurately measured volumes equivalent to 0.1-1.80 mgmL 
diclofenac sodium was transferred into a series of lOmL 
standard flasks. Then 2.5mL of chloranilic acid solution 
were added to each flask. The contents were mixed well and 
made up to volume by a solvent mixture of 1,4-dioxane and 
methanol made in the ratio 2:8. The absorbance was 
measured at 530nm against the reagent blank prepared 
simultaneously without diclofenac solution. 
Procedure for the assay of dosage forms 
About ten tablets were finely powered. An amount of the 
tablet powder equivalent of 50mg of the diclofenac sodium 
was weighed accurately and treated as described above for 
the standard drug solution. Filtration was performed in 
instantaneous where insoluble matter remained during 
preparation of the sample solutions. 
RESULTS AND DISCUSSION 
A chloranilic acid solution in 1,4-dioxane is yellow. The 
spectrum of 0.1% chloranilic acid in 1,4-dioxane possess a 
strong band at 440nm. Addition of diclofenac sodium to this 
solution causes an immediate change in the absorption 
spectrum, with a new characteristic band at 530nm (Fig 3.2), 
believed to be due to chloranilic acid radical anions. 
Reaction involved 
Chloranilic acid in organic solvents exist in un-ionized form 
and acts as a 7i-acceptor in similar manner to other quinones 
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[15,16]. Therefore, the addition of diclofenac sodium results 
in the formation of charge-transfer complex of n-7i and n-n* 
type. The complex is believed to be intermediate molecular 
association compound for which in appreciable polar 
solvents, complete transfer of charge takes place, producing 
the corresponding radical ion, which is responsible for the 
production of intense absorption band at 530nm. This 
predominant chroinogen with chloranilic acid is the reddish 
radical anion, which is formed by the dissociation of an 
original donor-acceptor (DA) complex. 
D + A^=T b—A ^=r D '+A • 
DA Complex (radical ions) 
The dissociation of the DA complex is promoted by the high 
ionizing power of solvent. Diclofenac acts as an electron 
donor and hence forms charge-transfer complex with TC-
acceptors. The donated electrons originate from the nitrogen 
atom and the aromatic ring forming n-n and n-K* complex 
respectively as shown in Fig. 3.1. 
Optimization of variables: 
To develop a quantitative method based on this reaction, a 
search was conducted for most effective 7r-acceptor. 
Chloranilic acid in 1,4-dioxane readily reacts with 
diclofenac sodium, forming a stable reddish chloranilic acid 
radical anion. 1,4-dioxane proved to be most suitable 
solvent. Other organic solvents were not suitable because 
the complex formed in these solvents either had low 
absorbance or precipitated on dilution. The reaction was 
instantaneous and the product remained stable for forty 
116 
minutes (Fig. 3.3) permitting quantitative determination to 
be carried out with good reproducibility. 
Performance characteristics: 
Under the proposed experimental conditions, there was a 
linear relationship between absorbance and final 
concentration over the range 10-180|agmL'^ of drug (Fig. 
3.5) with corresponding molar absorbitivity of 1.5x10" 
LmoT'cm"'. The jobs plot (Fig. 3.6) showed the molar ratio 
of 1:2 between diclofenac and the chloranilic acid. The 
reproducibility of the method was determined by the 
analysis of various samples covering the recommended 
concentration range for diclofenac sodium. The recoveries 
show, the method is reproducible, accurate and precise 
(Table 3.1). 
Application to dosage forms 
Results for determination of diclofeanc sodium in different 
dosage forms are also presented and show good agreement 
with those of the reference method [12]. This conclusion 
was confirmed by statistical analysis, showing no significant 
difference in accuracy and precision between the proposed 
and the reference methods (Table 3.2). 
Apparatus Method-II 
A Spectronic-20D'^ spectrophotometer, with 1cm cell, and a 
water bath (NSW-133) India was used during heat treatment 
and the colour development. 
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Reagents: 
All the reagents used were of analytical grade. 
A 0 .1% ferric ammonium sulphate (w/v) solution and O.OIM 
EDTA solution were prepared in O.OOIM sulphuric acid and 
conductivity water respectively. A O.IM solution of 1,10 
phenanthroline was prepared in ethnol. A mixed phosphate 
buffer (pH= 6.8) was used. 
Aqueous 0.1% (w/v) pure diclofenac solution was used for 
the preparation of calibration curve. 
Preparation of the calibration curve 
Mixed up l.OmL of buffer and 2mL of Iron (111) solution in 
lOmL volumetric flasks. Added sample solutions containing 
0.05-1.0mgL"' of diclofenac, followed by 0.5mL of 1,10-
phenanthroline. Heated for 25 minutes on a boiling water 
bath for the complete development of colour, then added 
l.OmL of EDTA solution, dilute up to the mark with 
distilled water, and measured the absorbance of the coloured 
solution against the reagent blank at 500nm. 
The proposed method was employed for diclofenac content 
estimation in commercial pharmaceutical preparations. A 
comparison of the reference method was also performed 
(Table 3.2). 
Ten tablets were crushed and finely powdered. An 
accurately weighed amount equivalent to 50mg of diclofenac 
was stirred in 50mL conductivity water. The residual solid 
was filtered on Whattman No-42 paper and washed with 
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water. The filtrate was made up to 50mL in a standard flask. 
The determination was carried in the same way as for the 
pure drugs in the calibration procedure. 
RESULTS AND DISCUSSION 
The absorption spectrum of the blank Iron (II) and 
Iron (111) complexes are shown in the Figure3.7. The 
maximum absorbance for both A and B is observed at 
500nm. The shapes of the absorption spectra are quite 
similar for A and B. 
The l ron(l l ) - l , 10-phenanthroline complex shows an intense 
red colour and is more stable than its corresponding ferric 
complex. The ferric complexes are shown to get reduced by 
reducing agents, which is the basis of present work. The 
reduction of Iron(lll) by diclofenac and the formation of 
Iron(lI)-l , 10- phenanthroline complex depends on pH. The 
development of colour is instantaneous in mixed phosphate 
buffer solution in the pH range 6 to 8. The photo-reduction 
of the ferric complex is avoided by adding a chelating agent 
such as ethylenediamine tetra-acetic acid to mask the 
excessive ferric ions after the colour development. Beer's 
law is obeyed in the concentration range 5-100|agmL'' 
(FigS.lO) with the molar absorbitivity of 4x 10^1moL''cm''. 
Some excipients with the dosage forms are found not to 
interfere (Table3.3). Paracetamol being an oxidant, interfers 
with the test, so the method can not be used for the 
determination of diclofenac in presence of paracetamol. The 
method is accurate and sensitive with respect to the 
microgram range of determination and higher molar 
absorbitivity, than are the earlier methods. 
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Introduction 
Cisapride is a gastrointest inal s t imulat ing agent, effective in 
the relief of gastrointest inal or esophagus disorders and in 
the promotion of gastric emptying of gast rointes t inal 
moti l i ty [1]. It is a prokinet ic agent believed to facil i tate 
acetyl choline release from the myenteric plexus of the gut 
[2] . It is chemically known as (+) c is -4-amino-5-chloro-N-
[ 1 - [ 3- f lourophenoxy )propyl ] - 3- methoxy -4 -p iper idyl ] -
2-methoxy benzamide (Figure 4.1). 
Fig 4 . 1 . Cisapride 
The drug is official in the British Pharmacopoeia [3] . The 
official method for the assay cisapride involves the t i trat ion 
with perchloric acid and the determination of end point by 
potent iometry . Three spectrophotometr ic methods for the 
determinat ion of cisapride are described [4]. The methods 
are based on the coupling of the diazotized drugs with the 
reagents such as chromotropic acid, pholoroglucinol and N-
(-1-naphthyl) ethylene diamine dihydrochloride to give 
coloured products having maximum absorbances at 530nm, 
450nm and 540nm respect ively. A colorimetr ic procedure for 
the est imation of cisapride in dosage forms has been 
desci ibed [5]. The method is based on the reaction of 
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cisapride with para-dimethylamine c innamaldehyde in 
presence of t r ichloroacet ic acid in methanol forming a 
sch i f f s base with ;^max. at 525nm. An HPLC method for the 
determinat ion of cisapride in tablets and oral suspensions in 
the presence of methyl polysi loxane is developed and 
val idated [6]. A reversed phase Cig Bandapak column and 
mobile phase comprising methanol and water were used. The 
drugs were detected and assayed at 275nm. Another HPLC 
method for the assay of cisapride in plasma is described [7]. 
Alkal inised samples of plasma are extracted with l.OmL of 
propanol in chloroform. Cisapride and internal standard are 
detected by flourescence monitoring at 295nm (exci ted) and 
350nm (emission) . Cisapride levels in human plasma are 
determined by RP-HPLC method [8] in which carbamazepine 
is used as internal standard. Cisapride and the internal 
standard are extracted from the plasma with 
dichloromethane and detected by UV detector at 370nm. A 
flourimetric method for the determination of cisapride in 
pharmaceut icals [9] under continuous and discont inuous 
condit ions is based on the fact that cisapride exhibits an 
emission spectrum with a maximum at a wavelength of 
355.2nm and excitat ion at 310nm. A spectrophotometr ic 
method for the determination of cisapride is based on its 
reaction with p-dimethylaminocinamaldhyde in phosphoric 
acid solution to form an orange chromogen [10] with 
maximum absorbance at 546.5nm and obeying Beer's law 
in the range 160-560ngmL"' . A UV Spectrophotometr ic 
method for the determination of cisapride in pharmaceut ical 
dosage forms is developed [11] with its concentrat ion range 
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between 2.0-20|igmL''. Two more methods are developed for 
the determination of cisapride [12]. In the first method the 
drug is reacted with N-dimethylaminocinnnamaldehyde in 
presence of sulphuric cid to form Schiff base having A,max. 
at 520nm and obeying Beer's law in the range 0.8-12)igmL' . 
In the second method, the drug solution reacts with folin-
cocalteu reagent in presence of sodium carbonate forming a 
blue chromogen with Xmax. at 880nm and linearity in the 
concentration range 0.4-8.0)j,gmL"'. The diazotization 
followed by coupling with N-(l-naphthyl) ehtylenediamine 
dihydrochloride or thiocol is studied with the aim of 
standardizing the methadol of cisapride pharmacentical 
analysis [13]. Reaction products with N-(l-napthyl) 
ethylenediamine has an absorption maximum at 535nm and 
products with thiocol at 495nm. The development of a 
spectrophotometric method based on the charge transfer 
formation of cisapride with iodine and catechol is reported 
[14]. Four extractive spectrophotometric methods for the 
assay of cisapride in pure and dosage forms based on the 
formation of chloroform soluble ion-associates under 
specified experimental conditions are described [15]. Four 
acidic dyes viz; Suprachen violet 3B, Erioglaucine A, 
Napthalene Bluel2 BR and Tropaelin 000 are utalized. 
Another spectrophotometric method for the determination of 
cisapride [16] in dosage forms is based on the oxidation of 
drug with nitrous acid followed by treatment with cresol fast 
violet acetate and measurement of the absorbance. 
In this chapter, two different procedures for the 
determination of cisapride are reported which are based on 
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redox reaction followed by spectrophotometric studies. In 
the first method, cisapride is treated with peroxydisulphate 
in presence of alkili. A yellow coloured product is obtained 
on heating, which has A,raax. 308nm. The second method 
involves acidic oxidation of cisapride with Ce(IV) to 
produce coloured product having Xmax, at 289nm. The 
methods are simple, accurate and can be satisfactorily 
applied to representative pharmaceutical formulations. 
EXPERIMENTAL 
Instrumentat ion Method-I 
DU-40 spectrophotometer (Beckman) was used for 
absorbance measurements. Controlled temperature water 
bath NSW-133 was used for heat treatment & colour 
development. 
Reagents 
All chemicals used were of analytical or pharmaceutical 
grade. Pure cisapride was obtained as a gift sample from 
Sigma Laboratories Mumbai (India) and prepared (ImgmL'') 
in dimethylformamide (DMF). Potassium persulphate and 
Sodium carbonate of O.IM each were prepared in double 
distilled water. 
Calibrat ion 
Aliquots of 0.1-l.OmgmL"' of the standard solution of 
cisapride were pipetted into a series of lOmL volumetric 
flasks. Optimum results were obtained after the addition of 
2.0mL of potassium persulphate and l.OmL of sodium 
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carbonate. The mixture was heated on a water bath at 85-
90°C for ten minutes to complete the reaction. After cooling 
to room temperature and dilution to lOmL with distilled 
water, the absorbance of the yellow coloured product was 
measured against the reagent blank at 308nm. 
Application of the proposed method 
About ten tablets were grinded to a fine powder. The tablet 
powder equivalent to 50mg of cisapride was weighed 
accurately and treated as described above. The insoluble 
matter remained during preparation of sample solution & 
was filtered off. 
RESULTS AND DISCUSSION 
The reaction mix,ture of cisapride and peroxydisulphate in 
alkali yields a yellow coloured product on heating having 
>.max. at 308nm (Fig 4.2), whereas the reagent blank shows 
Xmax. at 236nm. This type of reactions between aromatic 
amines and persulphate ions in aqueous base have been 
already cited in the literature [17-20]. Such reactions are 
appropriately named as Boyland-Sims oxidation. The 
mechanistic approach is believed to be an electrophilic 
displacement by the peroxide oxygen [21]. This involves the 
electrophilic attack by the persulphate ion on the nitrogen of 
the neutral amine at ortho orientation to from aryl 
hydroxylamine-0-sulphonate. This intermediate is then 
assumed to rearrange to the 0-aminoaryl sulphate. The intial 
attack at nitrogen is consistent with the work in other 
systems [22-25]. The postulated intermediate is more readily 
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oxidized than the start ing material . The yield of o-aminoaryl 
sulphate is believed to fall in strong alkali , a fact 
a t t r ibutable to more ready attack by persulphate on the 
dianion of the intermediate formed. 
Study of the proposed experimental condit ions. 
To obtain optimum condi t ions , the effect of different 
volume ratio of persulphate reagent and sodium carbonate 
are studied. It was observed that 2.0mL of O.IM persulphate 
(Fig. 4.3) and l.OmL of O.IM sodium carbonate (Fig. 4.4) 
gave the optimum results for the complete oxidation of 
c isapr ide. Under the optimum experimental condit ions the 
product is found to be stable after ten minutes of heating 
(Fig. 4.5) on a water bath at 85-90°C (Fig. 4.6) Beer 's law is 
obeyed over a narrow range from 10-100iJ,gL' (Fig.4.7) with 
the molar absorbit ivi ty of 4.63x10^ Lmol ' ' cm"'. 
The reproducibi l i ty of the procedure is studied by running 
various repl icate samples, each containing different amount 
of drug in the final solution (Table 4.2). In order to check 
the validi ty of the proposed method, the resul ts are 
compared with standard reference method [14]. The results 
are presented in the (Table 4.3). A study of possible 
interference caused by common diverse ions in dosage forms 
has been performed. The results are summarized in (Table 
4.1). 
The proposed method is sensit ive and rel iable at the 
recommended concentrat ion range. The stabil i ty of the 
colour is high and is not affected by moisture. Hence, the 
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proposed method can be recommended for the routine 
analysis of cisapride in drug control laboratories. 
Reagents Method-II 
The solution for cisapride (ImgmL' ') was prepared in 
dimethylformamide and Ce(IV) Stock solution (0.4M) was 
prepared in 2M nitric acid. 
Calibration Procedure 
To a series of lOmL standard flasks, appropriate volumes of 
standard solution of cisapride between 0.2-1.2mgmL"' were 
placed, followed by 1.5mL of Ce(IV) solution. The contents 
were mixed well and allowed to stand at room temperature. 
The volume was completed with dimethylformamide and the 
absorbance meaurements were recorded at 289mm against 
the reagent blank. 
Assay of dosage forms 
Ten tablets were grinded and powdered. The content of 
tablet power equivalent to 50mg of cisapride is dissolved in 
dimethylformamide, It is filtered instantaneously and 
proceeded as described under " Calibration Procedure". 
RESULTS AND DISCUSSION 
Ammonium eerie nitrate is a versatile oxidimetric reagent. 
Its high oxidation potential and excellent solution stability 
promoted us to use this reagent for the quantitative 
determination of cisapride. The absorption spectrum for 
Ce(IV) solution in 2M nitric acid shows ;\.max. at 357nm, 
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whereas its reaction product with cisapride gives absorption 
maximum at 289nm (Fig.4.8), thus indicating a 
hypsochromic shift with respect to ?iniax. of the cerium (IV) 
solution. The condit ions for the production of analyt ical ly 
useful measurements from Ce(IV) oxidation of cisapride 
were optimized so as to achieve maximum and reproducible 
absorbance measurements . The Ce(IV) concentrat ion and the 
nature and concentrat ion of the acid present have a marked 
influence on the analytical signal and were invest igated to 
obtained maximum absorbance reading. The effect of cerium 
(IV) concentrat ion for I.O mL of cisapcide is shown in 
(Figure 4.9). Nitric acid was the most effective medium for 
the sensit ive measurement of cisapride, and cerium (IV) 
concentrat ion of 2.73x10"^ molL ' ' was chosen for further 
s tudies . For the given concentrat ion of cer ium(IV), 2moIL' ' 
nitric acid produced maximum absorbance (Fig .4 .10) , hence 
this concentrat ion was chosen for the analyt ical procedure. 
Under the selected experimental condit ion described above, 
the cal ibrat ion graph was linear in the concentrat ion range 
20-120|.igmL' of cisapride (Fig.4.11) . The regression 
equation evaluated for the cal ibrat ion graph is 
A=0.21x+0.019, with the correlat ion coefficient of 0.9989. 
In order to apply suggested method for the analysis of 
pharmaceut ical dosage forms, the influence of commonly 
used excipients and addit ives was invest igated and the 
resul ts obtained are presented in Table 4 . 1 . Under the 
react ion condit ions used, the foreign substances tested did 
not interfere with the proposed method. 
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The precision of the method was determined by the percent 
error for ten multiple analyses of a series of solutions. The 
accuracy of analysis was tested by applying the 
recommended procedure (Table 4.2). The recoveries of the 
different amounts tested were determined from the standard 
reference graph and found to be satisfactory. 
The proposed spectrophotometric method has been 
successfully applied for the determination of cisapride in 
pharmaceutical dosage forms. The results obtained for this 
procedure were evaluated against the reference method [14] 
as shown in (Table 4.3). The proposed method has the 
advantage of being simple, accurate and sensitive for 
estimation of cisapride in pure form and formulations. 
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Introduction 
Nalidixic acid ( l - e thy l - l , 4 -d ihydro -7me thy I -4 -oxo- l , 8 -naph-
thyr id ine-3- Carboxylic acid) is an ant ibacter ial agent which has 
been occasional ly used intravenously for the t reatment of gram-
negative urinary tract infections since 1963. Renal failure is 
common amongst these pat ients and therefore it is necessary to 
monitor the plasma concentrat ion in order to prevent toxic or, on 
the other hand subtherapeutic levels . The major metabol i te , 
hydroxynal idixic acid is in vitro also active against Gra:m-
negative micro-organisms. Nal idixic acid has also been used for 
the prevent ion and treatment of infectious diseases in fish. 
Concern has arisen as to the presence of drug residues in fish 
t issues, and demand for a rapid, simple and sensit ive analyt ical 
method for determining them has increased. In man nal idixic acid 
is converted to the 7-hydroxymethyl metaboli te which is further 
oxidized to generate the dicarboxylic acid. 
A variety of methods have been described for the assay of 
nalidixic acid in biological media and dosage forms. A high 
pressure liquid chromatographic method has been developed for 
the s imultaneous assay of nal idixic acid and hydroxynal idixic 
acid in human plasma and urine [1]. The procedure measures 
both the compounds in the same sample. Chromatograms from 
control plasma and control urine yield a small blank which do 
not interfere with chromatograms from processed s tandards. A 
gas chromatographic method has been described for the 
determinat ion of nal idixic acid in plasma [2]. The method is 
sensit ive enough to determine therapeutic levels in l.OmL 
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plasma. Quantitation is carried out by means of both peak height 
measurements and peak area measurements. A method for the 
simultaneous determination of nalidixic acid and its analogues in 
cultured fish has been developed by high performance liquid 
chromatography [3]. The method also involves UV and 
flourometric detection, and Sep-pak Cu cartridges as a clean-up 
step. A selective TLC- densitometric method has been described 
by means of which nalidixic acid is determined in duplicate with 
good precision at therapeutic levels in a 100-}a,L plasma sample 
[4]. A high performance liquid chromatographic method for the 
analysis of nalidixic acid in plasma and urine has been described 
[5]. The statistical evaluation of this assay technique shows 
acceptable accuracy and precision at concentrations 2.0|j,gmL'' of 
plasma or 29.0)igmL'' of urine for samples augmented with the 
drug. A differential pulse polarographic method has been 
proposed for the determination of nalidixic acid and its 
metabolite in urine [6]. The method involves a simple extraction 
which is followed by controlled-potential analysis at the mercury 
pool electrode and at the HMDE. Another high performance 
liquid chromatographic method has been described [7] for the 
analysis of nalidixic acid and its two metabolites in human 
plasma and urine following the oral administration of a 
therapeutic dose in human. The applicability of this method to 
pharmacokinetic studies of nalidixic acid in humans has also 
been demonstrated. A gas chromatographic method has been 
established for the quantitative analysis of nalidixic acid [8]. 
The method is based on the derivatization of nalidixic acid with 
diazomethane, and 5-a-cholestane is used as an internal 
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Standard. Quantitation is achieved by measuring peak height 
ratios. The improved simplicity, specificity & accuracy of the 
method has been demonstrated for the quantitation of nalidixic 
acid in tablets. A high performance liquid chromatographic 
analysis of nalidixic acid and its hydroxymetabolite in plasma 
with an anion exchange system has been reported [9]. Proposed 
experimental parameters have also been studied. Another HPLC 
assay of nalidixic acid in plasma after alkylation with methyl 
iodide has been performed [10]. A packed column supercritical 
fluid chromatography has been employed [11] for the assay of 
nalidixic acid and metronidazole in bulk and combined dosage 
forms employing mebendazole as the internal standard. The 
validation of the method of assay of drugs has been done by the 
internal standard method 8L linear range for both the drugs has 
been 10-60|j.gmL'V A pH-induced difference spectrophotometric 
method for the simultaneous determination of metronidaole and 
nalidixic has been developed [12] in presence of each other as 
well as the excipients. The presence of identical isobestic points 
indicate the non-interference of excipients in the absorption at 
respective wavelengths. A spectrophototric method has been 
developed for the simultaneous determination of nalidixic acid 
and metronidazole in pharmaceutical preparation [13] using 
multicomponent mode of instrument. Another method for the 
simultaneous determination of these drugs in two component 
tablets and suspensions is based on the dual wavelength 
spectrophotometry [14] without any prior separation. Two more 
methods have been developed for the simultaneous determination 
of nalidixic acid & metronidazole. The methods used 
simultaneous equation and Q-analysis for their determination 
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[15]. The absorbance maxima of two drugs and their isobestic 
point are used as analytical wavelength. Another 
spectrophotometric procedure using multicomponent mode of 
analysis has been developed for the simultaneous determination 
of nalidixic acid and metronidazole in their dosage forms [16]. 
The method is based on the measurement of UV absorbance 
maxima of the two drugs. 
The literature survey for the assay of nalidixic acid has revealed 
that, a few methods are available in the visible range of 
spectrometry. Besides, the unstability of its reaction product 
with ferrous ammonium sulphate at maintained temperature 
(50+0.2°C) made us to develop a kinetic method which permits 
sensitive determination within a short limit of time. The study 
shows that the interaction between nalidixic acid and ferrous 
ammonium sulphate is first order reaction with respect to 
nalidixic acid. The proposed method can be successfully applied 
to the commercial dosage forms. 
EXPERIMENTAL 
Instrumentation 
DU-40 Spectrophotometer (Beckman) was used to record the 
spectra and Spectronic-ZOD"" (Milton Roy Co.) was used for 
absorbance Vs. time measurements. A temperature controlled 
water bath (NSW-133 India) was used to maintain a constant 
temperature (50 + 0.2"C). 
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Reagents 
All the Chemicals used were of analytical or pharmaceutical 
grade. Stock solution of 5.0xlO'^M ferrous ammomium sulphate 
was prepared in 1.0X10"' 'M sulphuric acid. Pure nalidixic acid 
(Himedia Labs. India) ImgmL"' was prepared in methanol. 
Calibration Procedure 
In 10ml volumetric flasks, the final concentration of standard 
pure solution of nalidixic acid between 0.2-0.8mgmL'' were 
placed, flowed by 1.5mL of ferrous ammonium sulphate. The 
flasks were immersed in a water bath maintained at 50+0.2°C. 
Each flask was taken out at a time interval of five minutes, 
cooled at room temperature and diluted upto the mark with 
distilled water. The contents were transferred to the 
spectrophotometric cell and the absorbance-time curve at 420nm 
was recorded against the blank containing all the constituents of 
sample except the drug. Calibration graph was prepared by a plot 
of logR (Initial rate of reaction) Vs. logC (nalidixic acid 
concentration). 
Analysis of nalidixic acid in tablets. 
The above proposed method was used for the estimation of 
nalidixic acid in tablets. About ten tablets were accurately 
weighed and grinded into fine powder. An amount of the tablet 
power equivalent to lOmg of nalidixic acid was weighed and 
treated as described for the calibration procedure. The insoluble 
matter was filtered instantaneously during the preparation of 
sample solutions. 
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RESULTS AND DISCUSSION 
The pure nalidixic acid solution in methanol shows two ?^max. in 
the ultravoilet region at 247nm and 338nm.A yellow coloured 
chromogen is formed; when ferrous ammonium sulphate is added, 
having A,max at 420nm (Fig.5.2),which indicates a bathochromic 
shift with respect to A,max. of nalidixic acid. 
The reaction product is unstable for forty minutes and 
hence the kinetic approach is preffered over conventional 
spectrophotometry, where unstability of colour preclude their 
efficacy. The kinetics of the formation of reaction product at 
maintained temperature (50+0.2°C) is studied at 420nm.The 
increase of absorbance is measured as a function of time. 
The redox reaction between nalidixic acid and ferrous ammonium 
sulphate leads to the formation of a coordination compound. The 
reduction of nalidixic acid results in hydrogenation of ethylene 
bond in azinone ring. The oxygen atoms, because of lone pair act 
as ligands and form coordinate bonds with Iron (III) as shown in 
Figure 5.1. 
Et . 
Me. N^ HH 
H ^ P J ' " reairangement 
•COOH 
Fig.5.1 Tentative reaction mechanism of nalidixic acid with 
ferrous ammonium sulphate. 
To study the rate of reaction with respect to nalidixic acid 
(keeping the ferrous ammonium sulphate cone, constant) at 
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50+0.2°C, absorbance versus time observat ions are recorded 
(Table 5.1). A plot of absorbance versus time (t) gives straight 
lines (Fig 5.3) whose slopes are used as a measure of reaction 
rate for solut ions containing different concentrat ion of nalidixic 
acid. The kinet ic studies with respect to nal idixic acid gave first 
order plots . Job's method of cont inuous variat ion establ ished that 
molar s toichiometr ic ratio of reaction between nalidixic acid and 
ferrous ammonium sulphate is 1:1 (Fig 5.5). Calibrat ion graphs 
constructed by plott ing initial rate of react ion(R) Vs. 
concentra t ion (C) or by logR Vs. logC (Fig 5.4(a,b)) show a 
linear re la t ionship with respect to the concentrat ion of nalidixic 
acid in the range 20-80|j,gmir'. The curve is also used to calculate 
order of react ion and found to be equal to +1.0. Validity of the 
proposed kinetic method was checked by running different 
concentrat ions of nal idixic acid, and the results obtained are 
presented in Table 5.2. The optimum reaction temperature was 
50+0.2°C, lower temperature showed inaccurate resul ts and the 
reaction was incomplete . On the other hand, higher temperature 
led to the decomposi t ion of reaction product. Some common 
excipients such as lactose, starch, fructose, glucose and sucrose 
which are usually present with dosage forms show no 
interference in determinat ion and the maximum tolerance amount 
was calculated using the procentual change in the absorbance of 
nal idixic acid measured value. The results are summarized in 
(Table 5.3). 
The proposed kinetic method has been successfully applied to the 
determinat ion of nal idixic acid in commercial dosage forms. The 
results are s tat is t ical ly compared with those obtained with the 
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reference method [17] and are presented in Table 5.4. The 
calculated 't' values suggested no significant difference between 
the two methods in terms of precision & accuracy. Hence the 
recommended method is at par with conventional spectrometric 
methods in terms of its reproducibi l i ty and the time required for 
the analysis . 
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Fig. 5.2. Absorption spectra of nalidixic acid-ferrous ammonium 
sulphate reaction product at 50+0.2°C. 
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ammonium sulphate cone, constant (2.55x10"^ mol L'^ ) at 50+ 0.2 °C . 
Nalidixic acid concentrations are; (a) 8.6x10"^ (b) 1.72x10'' (c) 2.15x10"^ 
(d) 2.58x10"^ and (e) 3.43x10^ molL\ 
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Abstract 
A method for the analysis of degraded products of amoxycillin, ampicillin and cloxacillin in drug formulations, 
obtained as a result of their base hydrolysis is described. Simultaneous spectrophotometric and volumetric determina-
tions of the antibiotic is based on the neutralization of the degraded product by dilute hydrochloric acid to get a pH 
~ 2 to be conducive for redox titration using potassium iodate as titrant. A red purple colour is developed in carbon 
tetrachloride at the end point. Spectrophotometry is done after separating the organic layer and measuring the 
absorbance of red-purple colour at X,„.„ 520 nm. The pathways of different degraded products and their oxidation 
mechanism is described on IR, TLC and UV spectroscopic studies. © 1999 Elsevier Science B.V. All rights reserved. 
Keywords: Amoxycillin; Ampicillin; Cloxacillin; Spcclropholoniclric and volumclric dclcrminalion; Simullancous dclcrmination; 
Pure and drug Ibrmulations 
1. Introduction ^^^ carried out by some oxidants prior to a base 
or acid catalysed reaction of antibiotics. The de-
A large number of methods for the analysis of S'"''^ '^ '^  hydrolysed products of antibiotics are ti-
ampicillin, amoxycillin and cloxacillin and related ^'''^^'^ quantitatively against oxidants such as 
antibiotics are described [1 -3] . Emphasis has been " § ' ' ["^^ ^"'^ '"'^^'^ solutions [5]. It is observed 
given on spectrophotometric and titrimetric meth- ^^'^^ *^^" hydrolytic conditions are changed from 
ods, because they are simple and easily manage- moderate concentration of alkali or acid to a 
able to the third world. The volumetric titrations ^ . ' , f °' " ' ' "^ '^' f •"'= .^?'.^  P " '^^l^"^. ^^^' ^ 
diiierent pathway of antibiotics mechanism re-
suits. The titrimetric method [4] described by al-
• Corresponding author. Tel; +91-571400515. kaline or enzymic hydrolysis followed by titration 
0731-7085/99/$ - see front matter © 1999 Elsevier Science B.V. All rights reserved. 
PII: 50731-7085(99)00205-8 
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with Hg(II) might suffer a setback. The use of 
nitric acid to neutralize the excess alkali before 
performing the titration may oxidize thiazolidine 
ring of the penicillin molecule and therefore could 
give erroneous results. The authors themselves 
reported better results with enzymic hydrolysis 
than alkaline hydrolysis. 
In the direct titration of antibiotics [5], with 
potassium iodate solution, strong acidic condi-
tions are prevailed. The acid plays a dual role, 
firstly it brings about acid hydrolysis, secondly it 
makes quantitative oxidation titration feasible. 
Two procedures are adopted [5]; in the first, the 
end point is detected by a colour change in the 
carbon tetrachloride layer from colourless to 
brown or deep red and in the second one, dye 
Amaranth is used to detect change in colour from 
deep red to pale yellow, as the dye is destroyed by 
an excess of iodate in aqueous medium at the 
neutralization point. 
The present manuscript describes the base 
catalysed hydrolysis of antibiotics in dilute 
sodium hydroxide solution. The hydrolysis 
product of antibiotics which contains sulphur 
derivatives, eg. -C-S-C groups, -S-H groups are 
quantitatively oxidized to sulphonic acid by titrat-
ing them against potassium iodate solution as 
oxidant, in dilute hydrochloric acid to prevail 
conducive atmosphere of pH ~ 2. The chemistry 
of this reductant system is described which shows 
the observed stoichiometric value of thiol group 
to iodate 1:2 which is consistent with theoretical 
value. The point of difference of our findings to 
that of previously described by Andrews titration 
[12] have been highlighted. The volumetric results 
are compared to spectrophotometric determina-
tion. The pathway and the oxidation mechanism 
of hydrolysis products of antibiotics have been 
proposed in the light of IR, TLC and spectropho-
tometric studies. 
2. Experimental 
2.1. Reagents 
All the experiments were performed with ana-
lytical reagent grade chemicals using double dis-
tilled water. Stock solution of antibiotics, 1 mg 
ml ~' were prepared by dissolving the pure and 
standard drugs (Himedia laboratories Bombay In-
dia) in water and stored in a well-dark and closed 
container to avoid direct contact with light. Hy-
drochloric acid standard solution (1.0 M), potas-
sium iodate and sodium hydroxide of 0.1 M each 
were prepared in distilled water. 
2.2. Apparatus 
A Bauch and Lomb Spectonic -200"^ and Spec-
tronic-1001 spUt beam spectrophotometer (Milton 
Roy Co.) with 1 cm path length quartz cells and a 
controlled water bath (NSW-133 India) were 
used. IR spectra of the isolated products were 
recorded on a spectrometer (Shimadzu IR-408, 
Japan) with KBr disc. 
2.3. General procedure 
2.3.1. Procedure I: simultaneous determination of 
penicillins by-volumetric titration against 
potassium iodate and spectrophotometry of 
coloured complex in organic layer 
Aliquots of 2.5 ml of 0.1 M sodium hydroxide 
were added into conical flasks followed by suit-
able volumes of each of the standard penicillin 
solutions, containing between 0.2-2.0 mg ml""' 
of amoxycillin and ampiciUin and 0.1-2.5 mg 
ml~' of cloxacillin. The contents (pH ~ 13) 
were shaken and placed in a water bath at 80°C 
for 10-15 min. After completion of the heat 
treatment, the mixture was cooled to room tem-
perature, followed by 0.5 ml of 1.0 M hydrochlo-
ric acid and 5 ml carbon tetrachloride. The 
mixture contents were titrated against potassium 
iodate with intermittent shaking. The end point 
was detected by a colour change from colourless 
to deep red colour in non-aqueous layer. For 
spectrophotometric determination, the non-
aqueous layer was removed using a 50 ml sepa-
rating funnel, dried over anhydrous sodium 
sulphate and measured absorbance at 520 nm 
against the blank, containing all the species ex-
cept drug. 
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2.3.2. Procedure II: determination of penicillins 
by spectrophotometric method 
To a known volume of amoxycillin solution 
ranging between 0.4-3.5 ml, ampicillin 0.4-2.8 ml 
and cloxacillin 0.1-2.5 ml, 2.5 ml of sodium 
hydroxide were added in a conical flask. The 
reaction mixture was kept for 10-15 min on a 
water bath at 80°C. After cooling to room tem-
perature, 1 ml of potassium iodate, 0.5 ml of 
hydrochloric acid and 5 ml carbon tetrachloride 
were added to the reaction mixture. The solution 
was shaken vigorously till a deep red colour was 
obtained in the organic layer. It was determined 
spectrophotometrically by the recommended pro-
cedure I. 
2.4. Assay of formations 
For the determination of penicillins in tablets 
and capsules, the above methods were used with 
no modification. About twenty tablets were 
grinded into finely divided powder. 100 mg of 
powder was accurately weighed and transferred 
into a 100 ml standard flask. Similarly the con-
tents of the capsules were weighed and dissolved 
equivalent to 100 mg in 0.1 1. The solution was 
well shaken for about 30 min to ensure a homoge-
neous solution. The residue was removed through 
Whatman No. 1 filter paper and the washings 
were taken into a final volume of 0.1 I followed by 
the recommended procedures I and II. 
3. Results and discussion 
The mechanism of penicillins in 0.1 M sodium 
hydroxide resulting in different degraded products 
can be rationalized in the light of IR, UV spectro-
scopic studies, TLC and molar stoichiometrics 
molar ratio of iodate to penicillin titration. The 
possible degradation pathways are illustrated in 
Fig. 1. 
3.1. TLC and spectrophotometric observations 
The presence of la has been suggested on the 
basis of the results obtained by TLC (Rf= 0.46 in 
a solvent system made v/v and comprising, 66% 
n-butanol, 17% glacial acetic acid, 17% water). 
This observation is in agreement with previous 
studies [6], which confirms the existence of 4-hy-
droxymethylene oxazolone la, (/?/=0.42 in the 
same solvent). Our studies of hydrolysis in O.IM 
NaOH at pH ~ 13 involving a single step reac-
tion using water bath at 80°C, show one X,„„ at 
240 nm, at reaction time of 15 min. This at-
tributes the existence of one of the three species 
viz; lb (i) or lb (ii) or lb (iii). Moreover the 
formation of penicilloic acid lb (i) from basic 
hydrolysis of penicillin is well established 
[7]Tables 1-3. On extending the time interval to 
12 h, another X a^^  at 270 nm is obtained, which 
further confirms the establishment of 1(a). The 
previous studies show the existence of 1(a) as 
degraded product of antibiotics in the pH range 
13-14 with UV spectroscopic analysis: X^ ^^ x 297.5. 
The slight difference in "K^.^^ value may be at-
tributed to different experimental conditions of 
hydrolysis, such as temperature, time of hydroly-
sis and pH etc. 
3.2. IR studies 
Three different spectra were taken, (i) pure 
amoxycillins, spectrum-A (Fig. 2) (ii) degraded in 
base catalysed hydrolysis, speclrum-B (Fig. 3) (iii) 
degraded base hydrolysed product treated with 
0.1 M hydrochloric acid followed by titration 
against KI03, spectrum-C (Fig. 4). 
The spectrum (B), compared with spectrum (A), 
revealed that the characteristic bands for different 
groups at specified frequencies in spectrum (A) 
are found, (i) missing, (ii) the formation at differ-
ent frequencies or (iii) remained unchanged. A 
broad flat portion (3450-2600 cm~') same as it 
was found in spectrum (A), attributed to primary 
aliphatic amine N-H (3450-3250 cm" ' ) , car-
boxylic (3300-2500 c m " ' ) and S-H (2600-2500 
c m " ' ) groupings. 
3.3. Missing and formation of new bands 
The bands are found missing in the range 
(1800-1500 c m - ' ) and (1350-1000 cm" ' ) result-
ing the formation of bands at 860 cm~' , 
680cm-' and in the range (1500-1350 cm" ' ) . 
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The identities of thiozolidine and secondary 
amine groups with different group frequencies 
lying in the range (1800-1510 cm~') are com-
pletely swept out. The second range of missing 
band (1350-1000 cm"') includes the groups e.g. 
CHj-S, ester etc. The two missmg ranges are 
revealed by a descending and ascending portion of 
spectra-B respectively. The formation of a broad 
band (1500-1350 cm"') is attributed to the pres-
ence of 4-hydroxy-methylene oxazolone (la), 
which is revealed by the groups frequencies C-0 
stretching and 0-H deformation vibration (1440-
1395cm~'). The ascending portion (1350 cm~' 
onwards) of spectrum B further describes the 
hydrolysis of the rest of the groups present. A 
strong peak at 860 cm"' may be attributed to 
S-0 (870-810 cm-') of sulphonic acid. The weak 
peak at 680 cm " ' suggests to disulphide -S-S, C-S 
A Degradation products, Su^e Stage hydrolysis at pH~ 13 
R-CONH-HC HC C-(( -  HCX: 
OC N C 
(CH3)2 
H-CO^H 
penicillin 
i OH 
R-CO-NH-C C t - (CH,) . y>2 
HOOC HN CH-COOH 
peniciUoic acid 
ib(i) 
- C O , 
"C=s_ OH 
N-
R-CO-N-CHj- (CH3)2 
CHCOOH 
peniUonic acid 
Ib(u) 
HS 
S, 
f^H-CH 
a - S ^ /V^^ COOH 
4-hydroxy methylene 
oxaxole-5(4H)-one 
la 
penctllemc acid 
Ib(m) 
B Oxidized products, Tntnmetncally and 
spectrophotometncally using lOo' as Oxidant ^ i 
I lyiOa' 
o 
II 
R—S=0 
I 
OH 
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IVb 
O O 
oxidation 11 11 . . 
< R - S - S - R °'"'^^°" 
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C-CH-, 
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- 1 2 
Fig 1 The possible degradation pathways of pencilline, followed by oxidation with lodate ions 
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Fig. 2. (i) Pure amoxycillin, spectrum-(A). 
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Fig. 3. (ii) Degraded in base catalysed hydrolysis, spectrura-(B). 
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(705-570 cm" ') and sulphoxides ( > S = O, C-S-
O at 730-690 cm"') after their partial oxidation 
to sulphonic acid in a semiquantitative manner as 
the sulphur compounds especially containing the 
group S-H, S-S are oxidized by mild oxidant or 
even atmospheric oxygen [8]. The spectrum -C, 
which is obtained after completing the titration 
against iodate in dilute acid conditions, gave the 
final product corresponding to strong peak at 835 
cm"', attributed to the presence of sulphonic acid 
quantitatively. 
The recommended procedure I describes simul-
taneous volumetric determination of penicillin 
against potassium iodate as oxidant in dilute acid 
medium. The deep-violet colour extracted in car-
bon tetrachloride at the equivalence point is stable 
for 2 h and has been studied spectrophotometri-
cally. The hydrolysis product of penicillins 
(amoxycillin, ampicillin and cloxacillin) which 
contained sulphur derivatives, i.e. -C-S-C (lb), 
-S-H groups are quantitatively oxidized to some 
intermediate species and finally to sulphonic acid 
whose identities have already been discussed in IR 
studies. The hydrolysis by dilute sodium hydrox-
ide solution has been carried out slowly at a 
constant temperature of 80°C with intermittent 
shaking. The excess of base is neutralized by 
adding hydrochloric acid (0.5 mmoJes) so that the 
reaction mixture attains a pH ~ 2. This provides 
a conducive environment of HjO"^  to concentra-
tion for carrying out quantitative titration of de-
graded products against potassium iodate. The 
reaction is summarized as follows; 
.6e-[HS-R + 3H20^ RSO3H -H 6H+65] X 2 Step I 
[IO3- +C\- -H6H++4e-->ICl-h3H30+]x3 
In the first step reaction a quantitative oxida-
tion of thiol to sulphonic acid followed by reduc-
tion of lOf to to ICl takes place which may be 
regarded as the reaction at equivalence point, but 
without any colour change. This shows that the 
stoichiometric value calculated theoretically 
should be of 2 mol of thiol group to 3 mol of 
iodate (1:1.5) which is inconsistent with experi-
mental value 1:2 [9]. However, the system still 
involves more iodate ions to make the end point 
visible due to its reduction to iodine monochlo-
•ooP 
90 
•0 
ij 
u (0 
z 
t SO 
J 
M 
5 401-
}0 
20 
10 • 
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Fig 4. (m) Degraded base hydrolyzed treated with I 0 M hydrochloric acid, followed by titration against KIO3, spectrura-(C) 
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ride and finally to free iodine. This is described in 
step II reaction which is given below: 
IO3- + 6H+ + CI- + 4e -"""-^nci + 3H,0 
), —..dissociation-
ici -• r + C1-
I-+H30'^''^''^'^H0I + H + 
5HOI°^"^°"4'-''"°"2l2 + IO3- + H- + 2H,0 
ofioddte 
In the step II, an over consumption of iodate 
takes place [10], thereby increasing the mole ratio 
of iodate from 1.5 to 2 mol which is consistent 
with the experimentally observed stoichiometry of 
1 mol thiol to 2 mol iodate. A stable red violet 
colour of free iodine in organic layer indicates the 
equivalence point. It is observed that further addi-
tion of iodate solution beyond the end point 
results no decolourization in mixture content. 
This means that a quantitative oxidation-reduc-
tion in dilute hydrochloric acid has taken place in 
[the system. The titrant iodate is reduced first to 
iodine monochloride and finally to free iodine to 
show a visible end point. The E" of iodate in 
dilute hydrochloric acid (1.19 V) is less than the 
E" in Andrew titration (1.23 V). The E° 1.19 V is 
|high enough to oxidize the degraded products of 
antibiotics containing derivatives. 
I In Andrev/s titration a strong hydrochloric acid 
(3-9 M) solution is required for reduction of 
iodate to iodine monochloride (IClf) complex. 
IO3 + 6H++2CI- -h4e--^ICU- +3H,0 
E° = 1.23 V 
During the course of titration with reducing 
agent, the presence of free iodine in the system 
also results from the further reduction of IClj" 
complex as given below: 
2ICl2-+2e-^l2 + 4Cl- E°= 1.06 V 
When the reducing agent has been consumed, 
the free iodine is titrated to form iodine 
monochloride complex. The end point is marked 
by the disappearance of the last free iodine. (A 
point of difference from our observation given in 
Step II). 
2I2 4- IO3- + 6H+ -I- lOCl - -> 5ICI2" + 3H2O 
The above conditions prevail if the concentra-
tion of the hydrochloric acid at the end point is at 
least 3 M. The iodate reacts quantitatively with 
reducing agents such as KI, I2, AS2O3, N2H4 and 
SO2 to iodine monochloride [11]. In many other 
cases the concentration of hydrochloric acid is not 
critical, but for Sb(III), it is 2.5-3.5 M; that is, 
the optimum acidity for reasonably rapid reaction 
varies from one reactant to another reactant [12]. 
The recommended procedure I, which describes 
the use of dilute hydrochloric acid is applied 
successfully to the simultaneous quantitative re-
duction of iodate to free iodine at the equivalence 
point, especially in a system which contains the 
degraded products of antibiotics with sulphur 
derivatives which can be oxidized by very mild 
oxidizing agents [10]. The half reaction of iodate 
in dilute acid solution with E° [II] can be pro-
posed as under. 
2IO3- + 12H+ -H lOe - -* P -f- 6H2O 
E° = 1.19 V 
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